cellular process (GO:0009987) | 0.26 | 27 | PLA2G6, TBP, CHCHD2, SNCAIP, GBA, SYNJ1, DNAJC13, UCHL1, MAPT, HTRA2, SNCA, PODXL, PINK1, EIF4G1, LRRK2, ATP13A2, NR4A2, FBXO7, GIGYF2, FGF20, ATXN3, GLUD2, ATXN2, PARK2, VPS13C, DNAJC6, PARK7 |
biological regulation (GO:0065007) | 0.39 | 27 | PLA2G6, TBP, CHCHD2, SNCAIP, GBA, SYNJ1, DNAJC13, UCHL1, MAPT, HTRA2, SNCA, PODXL, PINK1, EIF4G1, LRRK2, ATP13A2, NR4A2, FBXO7, GIGYF2, FGF20, ATXN3, VPS35, ATXN2, PARK2, VPS13C, DNAJC6, PARK7 |
regulation of biological process (GO:0050789) | 0.45 | 27 | PLA2G6, TBP, CHCHD2, SNCAIP, GBA, SYNJ1, DNAJC13, DNAJC6, MAPT, HTRA2, SNCA, PODXL, PINK1, EIF4G1, LRRK2, PARK7, ATP13A2, NR4A2, FBXO7, GIGYF2, FGF20, ATXN3, VPS35, ATXN2, PARK2, VPS13C, UCHL1 |
single-organism process (GO:0044699) | 0.48 | 27 | PLA2G6, TBP, SNCAIP, ADH1C, GBA, SYNJ1, DNAJC13, DNAJC6, MAPT, HTRA2, SNCA, PODXL, PINK1, EIF4G1, LRRK2, PARK7, ATP13A2, NR4A2, FBXO7, GIGYF2, FGF20, ATXN3, VPS35, GLUD2, PARK2, VPS13C, UCHL1 |
regulation of cellular process (GO:0050794) | 0.5 | 27 | PLA2G6, TBP, CHCHD2, SNCAIP, GBA, SYNJ1, DNAJC13, DNAJC6, MAPT, HTRA2, SNCA, PODXL, PINK1, EIF4G1, LRRK2, PARK7, ATP13A2, NR4A2, FBXO7, GIGYF2, FGF20, ATXN3, VPS35, ATXN2, PARK2, VPS13C, UCHL1 |
organic substance metabolic process (GO:0071704) | 0.63 | 24 | PLA2G6, TBP, CHCHD2, SNCAIP, ADH1C, GBA, SYNJ1, PARK7, HTRA2, SNCA, PINK1, EIF4G1, LRRK2, ATP13A2, NR4A2, FBXO7, GIGYF2, FGF20, ATXN3, GLUD2, ATXN2, PARK2, DNAJC6, UCHL1 |
metabolic process (GO:0008152) | 0.58 | 24 | PLA2G6, TBP, CHCHD2, SNCAIP, ADH1C, GBA, SYNJ1, PARK7, HTRA2, SNCA, PINK1, EIF4G1, LRRK2, ATP13A2, NR4A2, FBXO7, GIGYF2, FGF20, ATXN3, GLUD2, ATXN2, PARK2, DNAJC6, UCHL1 |
primary metabolic process (GO:0044238) | 0.69 | 23 | PLA2G6, TBP, CHCHD2, SNCAIP, GBA, SYNJ1, UCHL1, PARK7, HTRA2, SNCA, PINK1, EIF4G1, LRRK2, ATP13A2, NR4A2, FBXO7, GIGYF2, FGF20, ATXN3, GLUD2, ATXN2, PARK2, DNAJC6 |
single-organism cellular process (GO:0044763) | 0.65 | 23 | PLA2G6, SNCAIP, GBA, SYNJ1, UCHL1, DNAJC13, MAPT, HTRA2, SNCA, PODXL, PINK1, LRRK2, PARK7, ATP13A2, NR4A2, FBXO7, GIGYF2, FGF20, ATXN3, GLUD2, PARK2, VPS13C, DNAJC6 |
cellular metabolic process (GO:0044237) | 0.69 | 23 | PLA2G6, TBP, CHCHD2, SNCAIP, GBA, SYNJ1, PARK7, HTRA2, SNCA, PINK1, EIF4G1, LRRK2, ATP13A2, NR4A2, FBXO7, GIGYF2, FGF20, ATXN3, GLUD2, ATXN2, PARK2, DNAJC6, UCHL1 |
regulation of primary metabolic process (GO:0080090) | 1.08 | 19 | CHCHD2, ATXN2, LRRK2, PARK7, ATP13A2, PARK2, NR4A2, FBXO7, EIF4G1, HTRA2, TBP, GIGYF2, FGF20, PLA2G6, GBA, SNCA, ATXN3, UCHL1, PINK1 |
regulation of metabolic process (GO:0019222) | 1.02 | 19 | CHCHD2, ATXN2, LRRK2, PARK7, ATP13A2, PARK2, NR4A2, FBXO7, EIF4G1, HTRA2, TBP, GIGYF2, FGF20, PLA2G6, GBA, SNCA, ATXN3, UCHL1, PINK1 |
regulation of macromolecule metabolic process (GO:0060255) | 1.08 | 19 | CHCHD2, ATXN2, LRRK2, PARK7, TBP, PARK2, NR4A2, FBXO7, EIF4G1, HTRA2, ATP13A2, GIGYF2, FGF20, PLA2G6, GBA, SNCA, ATXN3, UCHL1, PINK1 |
cellular macromolecule metabolic process (GO:0044260) | 0.93 | 19 | EIF4G1, CHCHD2, ATXN2, LRRK2, ATP13A2, PARK2, PARK7, FBXO7, GIGYF2, HTRA2, DNAJC6, TBP, SNCAIP, FGF20, SNCA, UCHL1, ATXN3, NR4A2, PINK1 |
regulation of cellular metabolic process (GO:0031323) | 1.07 | 19 | ATXN2, CHCHD2, LRRK2, PLA2G6, ATP13A2, PARK2, NR4A2, FBXO7, EIF4G1, HTRA2, TBP, GIGYF2, FGF20, GBA, SNCA, UCHL1, ATXN3, PARK7, PINK1 |
macromolecule metabolic process (GO:0043170) | 0.83 | 19 | CHCHD2, ATXN2, LRRK2, TBP, PARK2, NR4A2, FBXO7, EIF4G1, HTRA2, DNAJC6, ATP13A2, GIGYF2, FGF20, SNCAIP, UCHL1, ATXN3, PARK7, PINK1, SNCA |
positive regulation of biological process (GO:0048518) | 1.2 | 19 | EIF4G1, VPS35, LRRK2, PLA2G6, PARK7, TBP, NR4A2, MAPT, PARK2, CHCHD2, HTRA2, ATP13A2, FGF20, GBA, SYNJ1, ATXN3, PODXL, PINK1, SNCA |
positive regulation of cellular process (GO:0048522) | 1.3 | 19 | EIF4G1, VPS35, LRRK2, PLA2G6, PARK7, TBP, NR4A2, MAPT, PARK2, CHCHD2, HTRA2, ATP13A2, FGF20, GBA, SYNJ1, ATXN3, PODXL, PINK1, SNCA |
negative regulation of biological process (GO:0048519) | 1.33 | 18 | PLA2G6, ATXN2, LRRK2, PODXL, ATP13A2, PARK2, NR4A2, MAPT, FBXO7, VPS35, HTRA2, GIGYF2, VPS13C, GBA, SNCA, UCHL1, PARK7, PINK1 |
cellular component organization (GO:0016043) | 1.24 | 17 | LRRK2, ATXN2, PARK7, ATP13A2, PARK2, NR4A2, MAPT, FBXO7, VPS13C, HTRA2, DNAJC13, SYNJ1, SNCA, UCHL1, ATXN3, DNAJC6, PINK1 |
cellular component organization or biogenesis (GO:0071840) | 1.22 | 17 | LRRK2, ATXN2, ATP13A2, FBXO7, NR4A2, MAPT, PARK2, VPS13C, HTRA2, DNAJC6, DNAJC13, SYNJ1, SNCA, UCHL1, ATXN3, PARK7, PINK1 |
regulation of response to stimulus (GO:0048583) | 1.54 | 16 | CHCHD2, LRRK2, TBP, NR4A2, PARK2, VPS35, HTRA2, VPS13C, FGF20, PLA2G6, GBA, SNCA, UCHL1, ATXN3, PARK7, PINK1 |
response to stimulus (GO:0050896) | 1.22 | 16 | EIF4G1, LRRK2, ATP13A2, NR4A2, MAPT, PARK2, PLA2G6, HTRA2, GIGYF2, GBA, SYNJ1, UCHL1, ATXN3, PARK7, PINK1, SNCA |
regulation of localization (GO:0032879) | 1.94 | 16 | VPS35, ATXN2, LRRK2, PARK7, ATP13A2, PODXL, MAPT, PARK2, PLA2G6, HTRA2, DNAJC13, SNCAIP, SYNJ1, DNAJC6, PINK1, SNCA |
regulation of protein metabolic process (GO:0051246) | 1.93 | 16 | EIF4G1, LRRK2, ATXN2, ATP13A2, FBXO7, UCHL1, PARK2, PLA2G6, HTRA2, GIGYF2, FGF20, GBA, SNCA, ATXN3, PARK7, PINK1 |
negative regulation of cellular process (GO:0048523) | 1.41 | 16 | PLA2G6, ATXN2, LRRK2, PODXL, ATP13A2, PARK2, NR4A2, FBXO7, VPS13C, HTRA2, GIGYF2, GBA, SNCA, UCHL1, PARK7, PINK1 |
cellular protein metabolic process (GO:0044267) | 1.63 | 15 | EIF4G1, LRRK2, PARK7, ATP13A2, PARK2, DNAJC6, FBXO7, SNCAIP, HTRA2, GIGYF2, FGF20, SNCA, ATXN3, UCHL1, PINK1 |
regulation of cellular protein metabolic process (GO:0032268) | 1.99 | 15 | PLA2G6, LRRK2, ATXN2, ATP13A2, FBXO7, PARK7, PARK2, EIF4G1, HTRA2, GIGYF2, FGF20, GBA, SNCA, UCHL1, PINK1 |
protein metabolic process (GO:0019538) | 1.45 | 15 | EIF4G1, LRRK2, ATP13A2, PARK2, DNAJC6, FBXO7, SNCAIP, HTRA2, GIGYF2, FGF20, SNCA, UCHL1, ATXN3, PARK7, PINK1 |
regulation of transport (GO:0051049) | 2.24 | 15 | VPS35, ATXN2, LRRK2, PARK7, ATP13A2, DNAJC6, PARK2, PLA2G6, HTRA2, DNAJC13, SNCAIP, SYNJ1, MAPT, PINK1, SNCA |
regulation of cellular component organization (GO:0051128) | 2.01 | 15 | PLA2G6, ATXN2, LRRK2, PARK7, ATP13A2, PODXL, MAPT, PARK2, VPS13C, HTRA2, SNCAIP, SYNJ1, DNAJC6, PINK1, SNCA |
localization (GO:0051179) | 1.4 | 15 | VPS35, ATXN2, LRRK2, ATP13A2, FBXO7, UCHL1, MAPT, PARK2, VPS13C, DNAJC13, SYNJ1, SNCA, ATXN3, PARK7, PINK1 |
regulation of biological quality (GO:0065008) | 1.68 | 14 | EIF4G1, VPS35, LRRK2, ATP13A2, PARK2, PARK7, FBXO7, SNCAIP, GIGYF2, VPS13C, PLA2G6, GBA, SNCA, PINK1 |
establishment of localization (GO:0051234) | 1.48 | 14 | VPS35, LRRK2, ATXN2, ATP13A2, PARK2, PARK7, FBXO7, DNAJC13, VPS13C, SYNJ1, UCHL1, MAPT, PINK1, SNCA |
response to stress (GO:0006950) | 1.8 | 14 | EIF4G1, LRRK2, ATP13A2, NR4A2, PARK2, PLA2G6, HTRA2, GIGYF2, GBA, SNCA, UCHL1, ATXN3, PARK7, PINK1 |
nitrogen compound metabolic process (GO:0006807) | 1.13 | 14 | CHCHD2, GLUD2, ATXN2, LRRK2, TBP, NR4A2, PARK2, EIF4G1, HTRA2, SNCAIP, PLA2G6, GBA, SNCA, ATXN3 |
regulation of signaling (GO:0023051) | 1.72 | 14 | VPS35, LRRK2, TBP, NR4A2, PARK2, PLA2G6, HTRA2, SNCAIP, FGF20, GBA, SNCA, UCHL1, PARK7, PINK1 |
regulation of cell communication (GO:0010646) | 1.73 | 14 | VPS35, LRRK2, TBP, NR4A2, PARK2, PLA2G6, HTRA2, SNCAIP, FGF20, GBA, SNCA, UCHL1, PARK7, PINK1 |
organelle organization (GO:0006996) | 2.02 | 13 | ATXN2, LRRK2, ATP13A2, FBXO7, PARK7, PARK2, HTRA2, DNAJC13, VPS13C, SNCA, ATXN3, MAPT, PINK1 |
organic substance biosynthetic process (GO:1901576) | 1.34 | 13 | CHCHD2, GLUD2, PLA2G6, TBP, NR4A2, PARK2, EIF4G1, FGF20, GBA, SYNJ1, ATXN3, PARK7, SNCA |
multicellular organismal process (GO:0032501) | 1.45 | 13 | EIF4G1, LRRK2, PARK7, NR4A2, PARK2, PLA2G6, HTRA2, GIGYF2, GBA, SYNJ1, UCHL1, MAPT, SNCA |
positive regulation of macromolecule metabolic process (GO:0010604) | 1.81 | 13 | CHCHD2, LRRK2, TBP, NR4A2, PARK2, PLA2G6, HTRA2, FGF20, GBA, SNCA, ATXN3, PARK7, PINK1 |
single-multicellular organism process (GO:0044707) | 1.78 | 13 | EIF4G1, LRRK2, PARK7, NR4A2, PARK2, PLA2G6, HTRA2, GIGYF2, GBA, SYNJ1, UCHL1, MAPT, SNCA |
regulation of signal transduction (GO:0009966) | 1.84 | 13 | VPS35, LRRK2, TBP, NR4A2, PARK2, PLA2G6, HTRA2, FGF20, GBA, SNCA, UCHL1, PARK7, PINK1 |
single-organism behavior (GO:0044708) | 3.79 | 13 | EIF4G1, LRRK2, NR4A2, MAPT, PARK2, PLA2G6, HTRA2, GIGYF2, SYNJ1, UCHL1, ATXN3, PARK7, SNCA |
transport (GO:0006810) | 1.51 | 13 | VPS35, ATXN2, LRRK2, ATP13A2, FBXO7, UCHL1, MAPT, PARK2, VPS13C, DNAJC13, SYNJ1, SNCA, PARK7 |
behavior (GO:0007610) | 3.47 | 13 | EIF4G1, LRRK2, PARK7, NR4A2, PARK2, PLA2G6, HTRA2, GIGYF2, SYNJ1, UCHL1, ATXN3, MAPT, SNCA |
cellular biosynthetic process (GO:0044249) | 1.37 | 13 | CHCHD2, GLUD2, PLA2G6, TBP, NR4A2, PARK2, EIF4G1, FGF20, GBA, SYNJ1, ATXN3, PARK7, SNCA |
biosynthetic process (GO:0009058) | 1.32 | 13 | EIF4G1, CHCHD2, GLUD2, TBP, NR4A2, PARK2, PLA2G6, FGF20, GBA, SYNJ1, ATXN3, PARK7, SNCA |
regulation of molecular function (GO:0065009) | 1.78 | 13 | PLA2G6, LRRK2, ATP13A2, PARK2, NR4A2, FBXO7, HTRA2, FGF20, GBA, SNCA, UCHL1, PARK7, PINK1 |
positive regulation of metabolic process (GO:0009893) | 1.74 | 13 | CHCHD2, LRRK2, TBP, NR4A2, PARK2, PLA2G6, HTRA2, FGF20, GBA, SNCA, ATXN3, PARK7, PINK1 |
developmental process (GO:0032502) | 1.36 | 12 | LRRK2, NR4A2, MAPT, PARK2, HTRA2, GIGYF2, GBA, SYNJ1, UCHL1, ATXN3, PODXL, SNCA |
single-organism metabolic process (GO:0044710) | 1.63 | 12 | PLA2G6, GLUD2, LRRK2, PARK7, PARK2, HTRA2, ADH1C, FGF20, GBA, SYNJ1, SNCA, PINK1 |
cellular response to stimulus (GO:0051716) | 1.97 | 12 | PLA2G6, LRRK2, ATP13A2, NR4A2, PARK2, HTRA2, GIGYF2, GBA, SNCA, ATXN3, PARK7, PINK1 |
negative regulation of macromolecule metabolic process (GO:0010605) | 2.01 | 12 | ATXN2, LRRK2, PARK7, ATP13A2, PARK2, UCHL1, FBXO7, GIGYF2, GBA, SNCA, NR4A2, PINK1 |
cellular response to stress (GO:0033554) | 2.51 | 12 | PLA2G6, LRRK2, ATP13A2, NR4A2, PARK2, HTRA2, GIGYF2, GBA, SNCA, ATXN3, PARK7, PINK1 |
regulation of organelle organization (GO:0033043) | 2.72 | 12 | PLA2G6, ATXN2, LRRK2, ATP13A2, PARK7, PARK2, HTRA2, VPS13C, SYNJ1, MAPT, PINK1, SNCA |
catabolic process (GO:0009056) | 2.38 | 12 | EIF4G1, GLUD2, FBXO7, PARK7, PARK2, PLA2G6, HTRA2, GBA, SYNJ1, ATXN3, UCHL1, PINK1 |
positive regulation of cellular metabolic process (GO:0031325) | 1.81 | 12 | CHCHD2, LRRK2, TBP, NR4A2, PARK2, PLA2G6, HTRA2, FGF20, GBA, SNCA, PARK7, PINK1 |
regulation of catalytic activity (GO:0050790) | 1.97 | 12 | LRRK2, ATP13A2, FBXO7, NR4A2, PARK2, HTRA2, FGF20, GBA, SNCA, UCHL1, PARK7, PINK1 |
regulation of biosynthetic process (GO:0009889) | 1.37 | 12 | CHCHD2, ATXN2, PLA2G6, TBP, NR4A2, PARK2, EIF4G1, GIGYF2, SNCA, ATXN3, PARK7, PINK1 |
organic substance catabolic process (GO:1901575) | 2.45 | 12 | EIF4G1, GLUD2, FBXO7, UCHL1, PARK2, PLA2G6, HTRA2, GBA, SYNJ1, ATXN3, PARK7, PINK1 |
response to chemical (GO:0042221) | 1.98 | 12 | LRRK2, ATP13A2, NR4A2, MAPT, PARK2, HTRA2, GBA, SYNJ1, ATXN3, PARK7, PINK1, SNCA |
regulation of macromolecule biosynthetic process (GO:0010556) | 1.43 | 12 | CHCHD2, ATXN2, PLA2G6, TBP, NR4A2, PARK2, EIF4G1, GIGYF2, SNCA, ATXN3, PARK7, PINK1 |
regulation of nitrogen compound metabolic process (GO:0051171) | 1.36 | 12 | EIF4G1, CHCHD2, ATXN2, TBP, NR4A2, PARK2, PLA2G6, GIGYF2, SNCA, ATXN3, PARK7, PINK1 |
regulation of multicellular organismal process (GO:0051239) | 1.87 | 12 | EIF4G1, LRRK2, PARK7, FBXO7, NR4A2, PARK2, PLA2G6, HTRA2, FGF20, GBA, SYNJ1, MAPT |
regulation of cellular biosynthetic process (GO:0031326) | 1.38 | 12 | CHCHD2, ATXN2, PLA2G6, TBP, NR4A2, PARK2, EIF4G1, GIGYF2, SNCA, ATXN3, PARK7, PINK1 |
negative regulation of metabolic process (GO:0009892) | 1.93 | 12 | LRRK2, ATXN2, ATP13A2, PARK2, NR4A2, FBXO7, GIGYF2, GBA, SNCA, UCHL1, PARK7, PINK1 |
negative regulation of cellular metabolic process (GO:0031324) | 2.01 | 12 | ATXN2, LRRK2, PARK7, ATP13A2, PARK2, UCHL1, FBXO7, GIGYF2, GBA, SNCA, NR4A2, PINK1 |
regulation of autophagy (GO:0010506) | 4.21 | 12 | VPS35, LRRK2, ATP13A2, PARK7, PARK2, HTRA2, VPS13C, GBA, SNCA, UCHL1, MAPT, PINK1 |
regulation of gene expression (GO:0010468) | 1.37 | 12 | CHCHD2, ATXN2, LRRK2, TBP, NR4A2, PARK2, EIF4G1, GIGYF2, SNCA, ATXN3, PARK7, PINK1 |
regulation of cellular macromolecule biosynthetic process (GO:2000112) | 1.46 | 11 | CHCHD2, ATXN2, TBP, NR4A2, PARK2, EIF4G1, GIGYF2, SNCA, ATXN3, PARK7, PINK1 |
regulation of cellular localization (GO:0060341) | 3.03 | 11 | PLA2G6, LRRK2, ATP13A2, PARK7, PARK2, HTRA2, DNAJC13, SNCAIP, SNCA, MAPT, PINK1 |
organic cyclic compound metabolic process (GO:1901360) | 1.26 | 11 | CHCHD2, ATXN2, LRRK2, TBP, NR4A2, PARK2, EIF4G1, HTRA2, SNCAIP, SNCA, ATXN3 |
regulation of phosphate metabolic process (GO:0019220) | 2.35 | 10 | PLA2G6, LRRK2, FBXO7, PARK7, PARK2, FGF20, GBA, SNCA, UCHL1, PINK1 |
negative regulation of response to stimulus (GO:0048585) | 2.52 | 10 | LRRK2, NR4A2, PARK2, HTRA2, VPS13C, GBA, SNCA, UCHL1, PARK7, PINK1 |
positive regulation of response to stimulus (GO:0048584) | 2.18 | 10 | VPS35, LRRK2, PARK7, PARK2, PLA2G6, HTRA2, FGF20, SNCA, ATXN3, PINK1 |
cellular catabolic process (GO:0044248) | 2.62 | 10 | EIF4G1, GLUD2, FBXO7, PARK7, PARK2, HTRA2, GBA, ATXN3, UCHL1, PINK1 |
negative regulation of signaling (GO:0023057) | 2.65 | 10 | PLA2G6, LRRK2, NR4A2, PARK2, HTRA2, GBA, SNCA, UCHL1, PARK7, PINK1 |
cellular nitrogen compound metabolic process (GO:0034641) | 1.22 | 10 | CHCHD2, ATXN2, LRRK2, TBP, NR4A2, PARK2, EIF4G1, HTRA2, GBA, ATXN3 |
signal transduction (GO:0007165) | 1.28 | 10 | PLA2G6, LRRK2, NR4A2, MAPT, VPS35, HTRA2, GIGYF2, FGF20, PARK7, PINK1 |
cellular response to chemical stimulus (GO:0070887) | 2.57 | 10 | LRRK2, ATP13A2, NR4A2, PARK2, HTRA2, GBA, SNCA, ATXN3, PARK7, PINK1 |
negative regulation of protein metabolic process (GO:0051248) | 2.82 | 10 | LRRK2, ATP13A2, PARK2, PARK7, FBXO7, GIGYF2, GBA, SNCA, UCHL1, PINK1 |
positive regulation of protein metabolic process (GO:0051247) | 2.43 | 10 | PLA2G6, LRRK2, PARK7, PARK2, HTRA2, FGF20, GBA, SNCA, ATXN3, PINK1 |
regulation of protein modification process (GO:0031399) | 2.32 | 10 | PLA2G6, LRRK2, FBXO7, PARK7, PARK2, FGF20, GBA, SNCA, UCHL1, PINK1 |
cellular aromatic compound metabolic process (GO:0006725) | 1.3 | 10 | CHCHD2, ATXN2, LRRK2, TBP, NR4A2, PARK2, EIF4G1, SNCAIP, SNCA, ATXN3 |
cellular protein modification process (GO:0006464) | 1.79 | 10 | LRRK2, PARK7, ATP13A2, PARK2, DNAJC6, FBXO7, FGF20, ATXN3, UCHL1, PINK1 |
regulation of vesicle-mediated transport (GO:0060627) | 3.63 | 10 | PLA2G6, ATXN2, LRRK2, ATP13A2, DNAJC6, PARK2, DNAJC13, SYNJ1, SNCA, PINK1 |
regulation of phosphorus metabolic process (GO:0051174) | 2.35 | 10 | PLA2G6, LRRK2, FBXO7, PARK7, PARK2, FGF20, GBA, SNCA, UCHL1, PINK1 |
macromolecule modification (GO:0043412) | 1.73 | 10 | LRRK2, ATP13A2, PARK2, DNAJC6, FBXO7, FGF20, UCHL1, ATXN3, PARK7, PINK1 |
protein modification process (GO:0036211) | 1.79 | 10 | LRRK2, PARK7, ATP13A2, PARK2, DNAJC6, FBXO7, FGF20, ATXN3, UCHL1, PINK1 |
regulation of intracellular signal transduction (GO:1902531) | 2.31 | 10 | PLA2G6, LRRK2, TBP, PARK7, PARK2, HTRA2, FGF20, GBA, UCHL1, PINK1 |
response to organic substance (GO:0010033) | 2.2 | 10 | LRRK2, NR4A2, MAPT, PARK2, HTRA2, GBA, SYNJ1, ATXN3, PARK7, SNCA |
single-organism localization (GO:1902578) | 2.09 | 10 | VPS35, ATP13A2, MAPT, PARK2, VPS13C, SYNJ1, UCHL1, PARK7, PINK1, SNCA |
regulation of phosphorylation (GO:0042325) | 2.5 | 10 | PLA2G6, LRRK2, FBXO7, PARK7, PARK2, FGF20, GBA, SNCA, UCHL1, PINK1 |
single-organism developmental process (GO:0044767) | 1.49 | 10 | LRRK2, PODXL, MAPT, HTRA2, GIGYF2, GBA, SYNJ1, UCHL1, NR4A2, SNCA |
negative regulation of cellular protein metabolic process (GO:0032269) | 2.88 | 10 | LRRK2, ATP13A2, PARK2, PARK7, FBXO7, GIGYF2, GBA, SNCA, UCHL1, PINK1 |
regulation of cellular component biogenesis (GO:0044087) | 3.08 | 10 | PLA2G6, ATXN2, LRRK2, PODXL, MAPT, PARK2, SNCAIP, SNCA, PARK7, PINK1 |
regulation of protein phosphorylation (GO:0001932) | 2.57 | 10 | PLA2G6, LRRK2, FBXO7, PARK7, PARK2, FGF20, GBA, SNCA, UCHL1, PINK1 |
negative regulation of cell communication (GO:0010648) | 2.66 | 10 | PLA2G6, LRRK2, NR4A2, PARK2, HTRA2, GBA, SNCA, UCHL1, PARK7, PINK1 |
locomotory behavior (GO:0007626) | 4.53 | 9 | LRRK2, PARK7, MAPT, PARK2, HTRA2, GIGYF2, SNCA, UCHL1, NR4A2 |
organonitrogen compound metabolic process (GO:1901564) | 2.32 | 9 | EIF4G1, GLUD2, LRRK2, NR4A2, PARK2, HTRA2, SNCAIP, GBA, SNCA |
negative regulation of signal transduction (GO:0009968) | 2.75 | 9 | LRRK2, NR4A2, PARK2, HTRA2, GBA, SNCA, UCHL1, PARK7, PINK1 |
positive regulation of transport (GO:0051050) | 2.9 | 9 | VPS35, ATP13A2, PARK7, PARK2, PLA2G6, HTRA2, SYNJ1, SNCA, PINK1 |
regulation of developmental process (GO:0050793) | 2.1 | 9 | EIF4G1, LRRK2, FBXO7, MAPT, PARK2, HTRA2, FGF20, SYNJ1, PINK1 |
cellular developmental process (GO:0048869) | 1.82 | 9 | LRRK2, DNAJC13, MAPT, HTRA2, GIGYF2, FGF20, NR4A2, UCHL1, PODXL |
regulation of response to stress (GO:0080134) | 2.53 | 9 | CHCHD2, LRRK2, PARK7, PARK2, HTRA2, VPS13C, GBA, ATXN3, PINK1 |
anatomical structure development (GO:0048856) | 1.58 | 9 | LRRK2, PODXL, NR4A2, PARK2, HTRA2, SYNJ1, UCHL1, ATXN3, MAPT |
positive regulation of signaling (GO:0023056) | 2.41 | 9 | VPS35, LRRK2, PARK7, PARK2, PLA2G6, HTRA2, FGF20, SNCA, PINK1 |
positive regulation of cellular protein metabolic process (GO:0032270) | 2.49 | 9 | PLA2G6, LRRK2, PARK7, PARK2, HTRA2, FGF20, GBA, SNCA, PINK1 |
organic substance transport (GO:0071702) | 2.15 | 9 | VPS35, ATXN2, ATP13A2, FBXO7, PARK7, PARK2, DNAJC13, VPS13C, SNCA |
cell communication (GO:0007154) | 3.04 | 9 | LRRK2, NR4A2, PARK2, FGF20, GBA, SNCA, UCHL1, ATXN3, PARK7 |
positive regulation of cell communication (GO:0010647) | 2.41 | 9 | VPS35, LRRK2, PARK7, PARK2, PLA2G6, HTRA2, FGF20, SNCA, PINK1 |
regulation of cell death (GO:0010941) | 2.43 | 9 | PLA2G6, LRRK2, ATP13A2, NR4A2, PARK2, HTRA2, SNCA, PARK7, PINK1 |
establishment of localization in cell (GO:0051649) | 2.47 | 9 | VPS35, FBXO7, MAPT, PARK2, VPS13C, SYNJ1, UCHL1, PARK7, SNCA |
cellular localization (GO:0051641) | 2.32 | 9 | VPS35, LRRK2, FBXO7, MAPT, PARK2, VPS13C, SYNJ1, UCHL1, SNCA |
regulation of catabolic process (GO:0009894) | 3.52 | 8 | LRRK2, ATP13A2, PARK7, PARK2, GBA, SNCA, ATXN3, PINK1 |
positive regulation of protein modification process (GO:0031401) | 2.7 | 8 | PLA2G6, LRRK2, PARK7, PARK2, FGF20, GBA, SNCA, PINK1 |
regulation of secretion (GO:0051046) | 3.2 | 8 | VPS35, LRRK2, ATP13A2, PARK2, PLA2G6, SNCAIP, SNCA, PINK1 |
positive regulation of biosynthetic process (GO:0009891) | 2.29 | 8 | CHCHD2, TBP, NR4A2, PARK2, PLA2G6, SNCA, PARK7, PINK1 |
regulation of intracellular transport (GO:0032386) | 3.58 | 8 | LRRK2, ATP13A2, PARK7, PARK2, HTRA2, DNAJC13, MAPT, PINK1 |
positive regulation of cellular biosynthetic process (GO:0031328) | 2.3 | 8 | CHCHD2, TBP, NR4A2, PARK2, PLA2G6, SNCA, PARK7, PINK1 |
regulation of secretion by cell (GO:1903530) | 3.28 | 8 | VPS35, LRRK2, ATP13A2, PARK2, PLA2G6, SNCAIP, SNCA, PINK1 |
regulation of protein transport (GO:0051223) | 3.12 | 8 | VPS35, LRRK2, ATP13A2, PARK7, PARK2, PLA2G6, HTRA2, PINK1 |
regulation of apoptotic process (GO:0042981) | 2.5 | 8 | PLA2G6, LRRK2, NR4A2, PARK2, HTRA2, SNCA, PARK7, PINK1 |
mitochondrion organization (GO:0007005) | 3.69 | 8 | LRRK2, PARK2, PARK7, FBXO7, HTRA2, VPS13C, SNCA, PINK1 |
regulation of protein localization (GO:0032880) | 2.88 | 8 | VPS35, LRRK2, ATP13A2, PARK7, PARK2, PLA2G6, HTRA2, PINK1 |
nucleobase-containing compound metabolic process (GO:0006139) | 1.35 | 8 | CHCHD2, ATXN2, LRRK2, TBP, NR4A2, PARK2, EIF4G1, ATXN3 |
positive regulation of signal transduction (GO:0009967) | 2.5 | 8 | VPS35, LRRK2, PARK7, PARK2, PLA2G6, HTRA2, FGF20, PINK1 |
regulation of kinase activity (GO:0043549) | 3.07 | 8 | LRRK2, PARK2, PARK7, FBXO7, GBA, SNCA, UCHL1, PINK1 |
cellular response to organic substance (GO:0071310) | 2.78 | 8 | LRRK2, NR4A2, PARK2, HTRA2, GBA, SNCA, ATXN3, PARK7 |
adult locomotory behavior (GO:0008344) | 5.3 | 8 | PARK7, MAPT, PARK2, HTRA2, GIGYF2, SNCA, UCHL1, NR4A2 |
regulation of programmed cell death (GO:0043067) | 2.49 | 8 | PLA2G6, LRRK2, NR4A2, PARK2, HTRA2, SNCA, PARK7, PINK1 |
positive regulation of molecular function (GO:0044093) | 2.23 | 8 | LRRK2, NR4A2, PARK2, HTRA2, FGF20, SNCA, PARK7, PINK1 |
positive regulation of cellular component organization (GO:0051130) | 2.68 | 8 | PLA2G6, PARK7, PARK2, HTRA2, SYNJ1, MAPT, PINK1, SNCA |
regulation of establishment of protein localization (GO:0070201) | 3.02 | 8 | VPS35, LRRK2, ATP13A2, PARK7, PARK2, PLA2G6, HTRA2, PINK1 |
negative regulation of phosphate metabolic process (GO:0045936) | 3.45 | 8 | LRRK2, FBXO7, PARK7, PARK2, GBA, SNCA, UCHL1, PINK1 |
regulation of nucleobase-containing compound metabolic process (GO:0019219) | 1.43 | 8 | CHCHD2, TBP, NR4A2, PARK2, SNCA, ATXN3, PARK7, PINK1 |
negative regulation of cell death (GO:0060548) | 2.95 | 8 | LRRK2, ATP13A2, NR4A2, PARK2, HTRA2, SNCA, PARK7, PINK1 |
regulation of nucleic acid-templated transcription (GO:1903506) | 1.55 | 8 | CHCHD2, TBP, NR4A2, PARK2, SNCA, ATXN3, PARK7, PINK1 |
single-organism transport (GO:0044765) | 2.18 | 8 | VPS35, ATP13A2, MAPT, PARK2, SYNJ1, UCHL1, PARK7, SNCA |
regulation of proteolysis (GO:0030162) | 3.2 | 8 | LRRK2, ATP13A2, PARK7, PARK2, HTRA2, GBA, SNCA, PINK1 |
regulation of RNA biosynthetic process (GO:2001141) | 1.55 | 8 | CHCHD2, TBP, NR4A2, PARK2, SNCA, ATXN3, PARK7, PINK1 |
regulation of neuron death (GO:1901214) | 4.19 | 8 | LRRK2, ATP13A2, NR4A2, PARK2, HTRA2, SNCA, PARK7, PINK1 |
negative regulation of neuron death (GO:1901215) | 4.57 | 8 | LRRK2, ATP13A2, NR4A2, PARK2, HTRA2, SNCA, PARK7, PINK1 |
response to oxidative stress (GO:0006979) | 3.9 | 8 | LRRK2, ATP13A2, NR4A2, PARK2, HTRA2, SNCA, PARK7, PINK1 |
heterocycle metabolic process (GO:0046483) | 1.31 | 8 | CHCHD2, ATXN2, LRRK2, TBP, NR4A2, PARK2, EIF4G1, ATXN3 |
response to oxygen-containing compound (GO:1901700) | 2.57 | 8 | LRRK2, NR4A2, PARK2, HTRA2, GBA, SYNJ1, PARK7, SNCA |
adult behavior (GO:0030534) | 4.79 | 8 | PARK7, MAPT, PARK2, HTRA2, GIGYF2, SNCA, UCHL1, NR4A2 |
negative regulation of phosphorylation (GO:0042326) | 3.7 | 8 | LRRK2, PARK2, PARK7, FBXO7, GBA, SNCA, UCHL1, PINK1 |
negative regulation of phosphorus metabolic process (GO:0010563) | 3.45 | 8 | LRRK2, PARK2, PARK7, FBXO7, GBA, SNCA, UCHL1, PINK1 |
negative regulation of protein modification process (GO:0031400) | 3.4 | 8 | LRRK2, PARK2, PARK7, FBXO7, GBA, SNCA, UCHL1, PINK1 |
regulation of cellular response to stress (GO:0080135) | 3.4 | 8 | CHCHD2, LRRK2, PARK7, PARK2, HTRA2, VPS13C, ATXN3, PINK1 |
regulation of transferase activity (GO:0051338) | 2.88 | 8 | LRRK2, FBXO7, PARK7, PARK2, GBA, SNCA, UCHL1, PINK1 |
regulation of transcription, DNA-templated (GO:0006355) | 1.56 | 8 | CHCHD2, TBP, NR4A2, PARK2, SNCA, ATXN3, PARK7, PINK1 |
phosphate-containing compound metabolic process (GO:0006796) | 2.16 | 8 | PLA2G6, LRRK2, ATP13A2, DNAJC6, FGF20, SYNJ1, SNCA, PINK1 |
phosphorus metabolic process (GO:0006793) | 2.15 | 8 | PLA2G6, LRRK2, ATP13A2, DNAJC6, FGF20, SYNJ1, SNCA, PINK1 |
regulation of mitochondrion organization (GO:0010821) | 4.34 | 8 | PLA2G6, LRRK2, ATP13A2, PARK7, PARK2, HTRA2, VPS13C, PINK1 |
negative regulation of protein phosphorylation (GO:0001933) | 3.79 | 8 | LRRK2, FBXO7, PARK7, PARK2, GBA, SNCA, UCHL1, PINK1 |
regulation of RNA metabolic process (GO:0051252) | 1.52 | 8 | CHCHD2, TBP, NR4A2, PARK2, SNCA, ATXN3, PARK7, PINK1 |
protein localization (GO:0008104) | 2.36 | 7 | VPS35, LRRK2, DNAJC13, PARK2, FBXO7, VPS13C, ATXN3 |
regulation of cellular catabolic process (GO:0031329) | 3.83 | 7 | LRRK2, ATP13A2, PARK7, PARK2, GBA, SNCA, PINK1 |
regulation of apoptotic signaling pathway (GO:2001233) | 3.83 | 7 | PLA2G6, LRRK2, NR4A2, PARK2, HTRA2, PARK7, PINK1 |
negative regulation of cellular component organization (GO:0051129) | 3.35 | 7 | LRRK2, ATXN2, PARK7, PARK2, VPS13C, SNCA, PINK1 |
homeostatic process (GO:0042592) | 2.61 | 7 | PLA2G6, LRRK2, ATP13A2, PARK2, GIGYF2, GBA, SNCA |
negative regulation of gene expression (GO:0010629) | 2.48 | 7 | LRRK2, NR4A2, PARK2, GIGYF2, SNCA, PARK7, PINK1 |
small molecule metabolic process (GO:0044281) | 2.38 | 7 | GLUD2, LRRK2, PARK7, ADH1C, GBA, SNCA, SYNJ1 |
positive regulation of cell death (GO:0010942) | 3.32 | 7 | PLA2G6, LRRK2, PARK7, PARK2, HTRA2, SNCA, PINK1 |
negative regulation of catalytic activity (GO:0043086) | 3.0 | 7 | LRRK2, PARK2, PARK7, FBXO7, GBA, SNCA, UCHL1 |
positive regulation of catalytic activity (GO:0043085) | 2.4 | 7 | LRRK2, NR4A2, HTRA2, FGF20, SNCA, PARK7, PINK1 |
cellular macromolecule catabolic process (GO:0044265) | 3.19 | 7 | EIF4G1, PARK2, UCHL1, FBXO7, HTRA2, ATXN3, PINK1 |
negative regulation of transport (GO:0051051) | 3.6 | 7 | VPS35, ATXN2, LRRK2, MAPT, PARK2, SNCA, PARK7 |
positive regulation of phosphorus metabolic process (GO:0010562) | 2.78 | 7 | PLA2G6, LRRK2, PARK7, FGF20, GBA, SNCA, PINK1 |
negative regulation of apoptotic process (GO:0043066) | 3.04 | 7 | LRRK2, NR4A2, PARK2, HTRA2, SNCA, PARK7, PINK1 |
negative regulation of molecular function (GO:0044092) | 2.74 | 7 | LRRK2, FBXO7, PARK7, PARK2, GBA, SNCA, UCHL1 |
proteolysis (GO:0006508) | 2.73 | 7 | PARK2, PARK7, FBXO7, HTRA2, ATXN3, UCHL1, PINK1 |
macromolecule localization (GO:0033036) | 2.34 | 7 | VPS35, LRRK2, DNAJC13, PARK2, FBXO7, VPS13C, ATXN3 |
negative regulation of programmed cell death (GO:0043069) | 3.02 | 7 | LRRK2, NR4A2, PARK2, HTRA2, SNCA, PARK7, PINK1 |
positive regulation of programmed cell death (GO:0043068) | 3.38 | 7 | PLA2G6, LRRK2, PARK7, PARK2, HTRA2, SNCA, PINK1 |
regulation of macroautophagy (GO:0016241) | 4.98 | 7 | VPS35, LRRK2, ATP13A2, UCHL1, VPS13C, GBA, PINK1 |
regulation of hydrolase activity (GO:0051336) | 2.53 | 7 | LRRK2, ATP13A2, PARK7, HTRA2, FGF20, SNCA, PINK1 |
positive regulation of phosphate metabolic process (GO:0045937) | 2.78 | 7 | PLA2G6, LRRK2, PARK7, FGF20, GBA, SNCA, PINK1 |
regulation of protein kinase activity (GO:0045859) | 3.15 | 7 | LRRK2, PARK7, FBXO7, GBA, SNCA, UCHL1, PINK1 |
positive regulation of nitrogen compound metabolic process (GO:0051173) | 2.29 | 7 | CHCHD2, TBP, NR4A2, PARK2, PLA2G6, PARK7, PINK1 |
negative regulation of intracellular signal transduction (GO:1902532) | 3.63 | 7 | LRRK2, PARK7, PARK2, HTRA2, GBA, UCHL1, PINK1 |
cellular response to oxidative stress (GO:0034599) | 4.7 | 7 | LRRK2, ATP13A2, NR4A2, HTRA2, SNCA, PARK7, PINK1 |
macromolecule catabolic process (GO:0009057) | 3.0 | 7 | EIF4G1, PARK2, UCHL1, FBXO7, HTRA2, ATXN3, PINK1 |
RNA metabolic process (GO:0016070) | 1.59 | 7 | CHCHD2, ATXN2, TBP, NR4A2, PARK2, EIF4G1, ATXN3 |
nucleic acid metabolic process (GO:0090304) | 1.46 | 7 | CHCHD2, ATXN2, TBP, NR4A2, PARK2, EIF4G1, ATXN3 |
cellular nitrogen compound biosynthetic process (GO:0044271) | 1.59 | 7 | CHCHD2, TBP, NR4A2, PARK2, EIF4G1, GBA, ATXN3 |
response to external stimulus (GO:0009605) | 2.55 | 7 | PLA2G6, LRRK2, NR4A2, PARK2, GBA, SNCA, MAPT |
positive regulation of organelle organization (GO:0010638) | 3.38 | 7 | PLA2G6, PARK7, PARK2, HTRA2, SYNJ1, MAPT, PINK1 |
regulation of protein catabolic process (GO:0042176) | 3.83 | 7 | LRRK2, ATP13A2, PARK7, PARK2, GBA, ATXN3, PINK1 |
regulation of multicellular organismal development (GO:2000026) | 2.31 | 7 | EIF4G1, LRRK2, PARK2, MAPT, FBXO7, FGF20, SYNJ1 |
organic hydroxy compound metabolic process (GO:1901615) | 3.84 | 7 | NR4A2, PARK2, ADH1C, SNCAIP, GBA, SNCA, SYNJ1 |
negative regulation of apoptotic signaling pathway (GO:2001234) | 4.42 | 6 | LRRK2, NR4A2, PARK2, HTRA2, PARK7, PINK1 |
regulation of intracellular protein transport (GO:0033157) | 3.8 | 6 | LRRK2, ATP13A2, PARK7, PARK2, HTRA2, PINK1 |
cellular macromolecule biosynthetic process (GO:0034645) | 1.66 | 6 | CHCHD2, TBP, NR4A2, PARK2, EIF4G1, ATXN3 |
macromolecular complex subunit organization (GO:0043933) | 2.14 | 6 | LRRK2, ATXN2, DNAJC6, PARK2, SYNJ1, ATXN3 |
cell differentiation (GO:0030154) | 2.14 | 6 | LRRK2, DNAJC13, MAPT, GIGYF2, FGF20, NR4A2 |
modulation of synaptic transmission (GO:0050804) | 4.09 | 6 | PLA2G6, LRRK2, PARK2, SNCAIP, SNCA, PINK1 |
regulation of cellular protein localization (GO:1903827) | 3.43 | 6 | LRRK2, ATP13A2, PARK7, PARK2, HTRA2, PINK1 |
positive regulation of gene expression (GO:0010628) | 2.35 | 6 | CHCHD2, TBP, NR4A2, PARK2, PARK7, PINK1 |
cell surface receptor signaling pathway (GO:0007166) | 2.09 | 6 | VPS35, LRRK2, NR4A2, PLA2G6, GIGYF2, FGF20 |
intracellular signal transduction (GO:0035556) | 2.39 | 6 | LRRK2, PARK7, HTRA2, FGF20, MAPT, PINK1 |
organic cyclic compound biosynthetic process (GO:1901362) | 1.66 | 6 | CHCHD2, TBP, NR4A2, PARK2, SNCA, ATXN3 |
regulation of MAPK cascade (GO:0043408) | 3.22 | 6 | LRRK2, UCHL1, PARK2, FGF20, GBA, PINK1 |
single-organism catabolic process (GO:0044712) | 3.21 | 6 | PLA2G6, GLUD2, PARK7, PARK2, GBA, SYNJ1 |
single-organism biosynthetic process (GO:0044711) | 2.8 | 6 | PLA2G6, GLUD2, PARK7, FGF20, GBA, SYNJ1 |
positive regulation of multicellular organismal process (GO:0051240) | 2.49 | 6 | EIF4G1, PARK7, PARK2, PLA2G6, SYNJ1, MAPT |
positive regulation of macromolecule biosynthetic process (GO:0010557) | 2.39 | 6 | CHCHD2, TBP, NR4A2, PARK2, PARK7, PINK1 |
positive regulation of apoptotic process (GO:0043065) | 3.38 | 6 | PLA2G6, PARK7, PARK2, HTRA2, SNCA, PINK1 |
positive regulation of nucleobase-containing compound metabolic process (GO:0045935) | 2.35 | 6 | CHCHD2, TBP, NR4A2, PARK2, PARK7, PINK1 |
lipid metabolic process (GO:0006629) | 2.68 | 6 | PLA2G6, HTRA2, FGF20, GBA, SYNJ1, SNCA |
regulation of cellular protein catabolic process (GO:1903362) | 4.23 | 6 | LRRK2, ATP13A2, PARK7, PARK2, GBA, PINK1 |
regulation of cell differentiation (GO:0045595) | 2.42 | 6 | EIF4G1, LRRK2, PARK2, MAPT, FBXO7, SYNJ1 |
macromolecule biosynthetic process (GO:0009059) | 1.61 | 6 | CHCHD2, TBP, NR4A2, PARK2, EIF4G1, ATXN3 |
aromatic compound biosynthetic process (GO:0019438) | 1.7 | 6 | CHCHD2, TBP, NR4A2, PARK2, SNCA, ATXN3 |
positive regulation of intracellular signal transduction (GO:1902533) | 2.95 | 6 | PLA2G6, LRRK2, PARK7, PARK2, FGF20, PINK1 |
cellular lipid metabolic process (GO:0044255) | 2.92 | 6 | PLA2G6, HTRA2, FGF20, GBA, SYNJ1, SNCA |
cellular response to oxygen-containing compound (GO:1901701) | 3.22 | 6 | LRRK2, NR4A2, PARK2, HTRA2, SNCA, PARK7 |
positive regulation of phosphorylation (GO:0042327) | 2.9 | 6 | PLA2G6, LRRK2, PARK7, FGF20, SNCA, PINK1 |
regulation of protein stability (GO:0031647) | 4.33 | 6 | VPS35, PARK2, PARK7, FBXO7, SNCA, PINK1 |
chemical homeostasis (GO:0048878) | 2.97 | 6 | PLA2G6, LRRK2, ATP13A2, PARK2, GBA, SNCA |
single-organism organelle organization (GO:1902589) | 2.68 | 6 | PARK2, MAPT, FBXO7, SNCA, ATXN3, PINK1 |
positive regulation of proteolysis (GO:0045862) | 3.86 | 6 | LRRK2, PARK2, HTRA2, GBA, SNCA, PINK1 |
positive regulation of protein phosphorylation (GO:0001934) | 2.95 | 6 | PLA2G6, LRRK2, PARK7, FGF20, SNCA, PINK1 |
regulation of mitophagy (GO:1903146) | 5.99 | 6 | ATP13A2, PARK7, PARK2, HTRA2, VPS13C, PINK1 |
negative regulation of kinase activity (GO:0033673) | 4.22 | 5 | GBA, FBXO7, PARK7, PARK2, UCHL1 |
regulation of membrane potential (GO:0042391) | 3.89 | 5 | PARK7, PARK2, LRRK2, PINK1, SNCA |
negative regulation of transferase activity (GO:0051348) | 3.87 | 5 | GBA, PARK2, PARK7, FBXO7, UCHL1 |
positive regulation of apoptotic signaling pathway (GO:2001235) | 4.58 | 5 | PLA2G6, PARK2, PARK7, PINK1, HTRA2 |
RNA biosynthetic process (GO:0032774) | 1.84 | 5 | TBP, PARK2, CHCHD2, ATXN3, NR4A2 |
positive regulation of secretion (GO:0051047) | 3.85 | 5 | ATP13A2, PLA2G6, VPS35, PINK1, SNCA |
organonitrogen compound biosynthetic process (GO:1901566) | 2.85 | 5 | GBA, NR4A2, GLUD2, EIF4G1, SNCA |
ion homeostasis (GO:0050801) | 3.42 | 5 | ATP13A2, PLA2G6, PARK2, SNCA, LRRK2 |
proteolysis involved in cellular protein catabolic process (GO:0051603) | 3.59 | 5 | PARK2, ATXN3, UCHL1, FBXO7, PINK1 |
movement of cell or subcellular component (GO:0006928) | 2.61 | 5 | MAPT, NR4A2, UCHL1, PODXL, LRRK2 |
cell-cell signaling (GO:0007267) | 3.35 | 5 | ATXN3, PARK7, PARK2, SNCA, FGF20 |
regulation of neuron apoptotic process (GO:0043523) | 4.47 | 5 | NR4A2, PARK2, PARK7, PINK1, SNCA |
negative regulation of neuron apoptotic process (GO:0043524) | 4.82 | 5 | NR4A2, PARK2, PARK7, PINK1, SNCA |
peptidyl-amino acid modification (GO:0018193) | 2.98 | 5 | ATP13A2, PARK7, FGF20, LRRK2, PINK1 |
positive regulation of secretion by cell (GO:1903532) | 3.93 | 5 | ATP13A2, PLA2G6, VPS35, PINK1, SNCA |
inorganic ion homeostasis (GO:0098771) | 3.43 | 5 | ATP13A2, PLA2G6, PARK2, SNCA, LRRK2 |
positive regulation of protein transport (GO:0051222) | 3.61 | 5 | ATP13A2, PLA2G6, VPS35, PINK1, HTRA2 |
positive regulation of establishment of protein localization (GO:1904951) | 3.49 | 5 | ATP13A2, PLA2G6, VPS35, PINK1, HTRA2 |
modification-dependent macromolecule catabolic process (GO:0043632) | 3.69 | 5 | FBXO7, ATXN3, UCHL1, PARK2, PINK1 |
nucleic acid-templated transcription (GO:0097659) | 1.91 | 5 | TBP, ATXN3, CHCHD2, PARK2, NR4A2 |
response to endogenous stimulus (GO:0009719) | 2.79 | 5 | GBA, NR4A2, PARK2, SNCA, LRRK2 |
regulation of neurogenesis (GO:0050767) | 3.21 | 5 | EIF4G1, MAPT, PARK2, SYNJ1, LRRK2 |
regulation of cellular amide metabolic process (GO:0034248) | 3.88 | 5 | ATXN2, PLA2G6, GIGYF2, EIF4G1, PINK1 |
regulation of protein serine/threonine kinase activity (GO:0071900) | 3.58 | 5 | GBA, UCHL1, FBXO7, SNCA, LRRK2 |
positive regulation of hydrolase activity (GO:0051345) | 2.91 | 5 | SNCA, LRRK2, FGF20, PINK1, HTRA2 |
anatomical structure morphogenesis (GO:0009653) | 2.53 | 5 | GBA, NR4A2, MAPT, UCHL1, LRRK2 |
regulation of peptidase activity (GO:0052547) | 3.75 | 5 | ATP13A2, PARK7, HTRA2, PINK1, SNCA |
protein modification by small protein conjugation or removal (GO:0070647) | 2.95 | 5 | FBXO7, ATXN3, UCHL1, PARK2, PINK1 |
negative regulation of oxidative stress-induced cell death (GO:1903202) | 6.23 | 5 | PARK2, PARK7, LRRK2, HTRA2, PINK1 |
regulation of cell development (GO:0060284) | 3.01 | 5 | EIF4G1, MAPT, PARK2, SYNJ1, LRRK2 |
nitrogen compound transport (GO:0071705) | 3.54 | 5 | ATP13A2, PARK7, PARK2, SNCA, ATXN2 |
positive regulation of mitochondrion organization (GO:0010822) | 4.61 | 5 | PLA2G6, PARK2, PARK7, PINK1, HTRA2 |
regulation of nervous system development (GO:0051960) | 3.1 | 5 | EIF4G1, MAPT, PARK2, SYNJ1, LRRK2 |
organelle localization (GO:0051640) | 3.94 | 5 | SYNJ1, MAPT, UCHL1, LRRK2, SNCA |
regulation of oxidative stress-induced cell death (GO:1903201) | 5.9 | 5 | PARK2, PARK7, LRRK2, HTRA2, PINK1 |
regulation of proteasomal protein catabolic process (GO:0061136) | 4.78 | 5 | GBA, PARK7, PARK2, LRRK2, PINK1 |
system process (GO:0003008) | 2.3 | 5 | PARK2, PLA2G6, UCHL1, GIGYF2, SYNJ1 |
regulation of proteolysis involved in cellular protein catabolic process (GO:1903050) | 4.32 | 5 | GBA, PARK7, PARK2, LRRK2, PINK1 |
negative regulation of intrinsic apoptotic signaling pathway (GO:2001243) | 5.21 | 5 | PARK2, PARK7, LRRK2, HTRA2, PINK1 |
heterocycle biosynthetic process (GO:0018130) | 1.7 | 5 | TBP, PARK2, CHCHD2, ATXN3, NR4A2 |
positive regulation of nucleic acid-templated transcription (GO:1903508) | 2.56 | 5 | TBP, NR4A2, PARK2, CHCHD2, PARK7 |
response to abiotic stimulus (GO:0009628) | 2.8 | 5 | GBA, NR4A2, ATXN3, HTRA2, PINK1 |
neurological system process (GO:0050877) | 2.64 | 5 | PARK2, PLA2G6, GIGYF2, UCHL1, SYNJ1 |
autophagy (GO:0006914) | 3.82 | 5 | FBXO7, PARK7, PARK2, LRRK2, PINK1 |
modification-dependent protein catabolic process (GO:0019941) | 3.71 | 5 | PARK2, ATXN3, UCHL1, FBXO7, PINK1 |
positive regulation of catabolic process (GO:0009896) | 3.94 | 5 | GBA, ATXN3, SNCA, PARK2, LRRK2 |
establishment of protein localization (GO:0045184) | 2.53 | 5 | DNAJC13, VPS35, FBXO7, VPS13C, PINK1 |
organophosphate metabolic process (GO:0019637) | 3.04 | 5 | PLA2G6, LRRK2, SYNJ1, FGF20, SNCA |
positive regulation of RNA metabolic process (GO:0051254) | 2.51 | 5 | TBP, CHCHD2, PARK2, PARK7, NR4A2 |
cellular component disassembly (GO:0022411) | 3.52 | 5 | FBXO7, DNAJC6, PARK2, SYNJ1, PINK1 |
positive regulation of transcription, DNA-templated (GO:0045893) | 2.56 | 5 | TBP, NR4A2, PARK2, CHCHD2, PARK7 |
cation homeostasis (GO:0055080) | 3.46 | 5 | ATP13A2, PLA2G6, PARK2, SNCA, LRRK2 |
response to inorganic substance (GO:0010035) | 3.56 | 5 | ATP13A2, PARK7, PARK2, SNCA, LRRK2 |
regulation of response to oxidative stress (GO:1902882) | 5.62 | 5 | PARK2, PARK7, LRRK2, HTRA2, PINK1 |
negative regulation of response to oxidative stress (GO:1902883) | 6.23 | 5 | PARK2, PARK7, LRRK2, HTRA2, PINK1 |
oxidation-reduction process (GO:0055114) | 2.91 | 5 | PARK7, GLUD2, ADH1C, PINK1, SNCA |
multi-organism process (GO:0051704) | 2.65 | 5 | TBP, PLA2G6, MAPT, PARK2, EIF4G1 |
locomotion (GO:0040011) | 2.91 | 5 | NR4A2, MAPT, PODXL, LRRK2, PLA2G6 |
single organism signaling (GO:0044700) | 3.25 | 5 | PARK2, PARK7, ATXN3, SNCA, FGF20 |
regulation of cellular response to oxidative stress (GO:1900407) | 5.72 | 5 | PARK7, PARK2, LRRK2, PINK1, HTRA2 |
vesicle-mediated transport (GO:0016192) | 2.72 | 5 | VPS13C, VPS35, SYNJ1, LRRK2, SNCA |
intracellular transport (GO:0046907) | 2.67 | 5 | UCHL1, MAPT, FBXO7, VPS35, VPS13C |
positive regulation of developmental process (GO:0051094) | 2.77 | 5 | EIF4G1, MAPT, PARK2, SYNJ1, PINK1 |
negative regulation of cellular response to oxidative stress (GO:1900408) | 6.23 | 5 | PARK2, PARK7, LRRK2, HTRA2, PINK1 |
negative regulation of organelle organization (GO:0010639) | 4.07 | 5 | VPS13C, PARK2, LRRK2, PINK1, SNCA |
positive regulation of RNA biosynthetic process (GO:1902680) | 2.54 | 5 | TBP, NR4A2, PARK2, CHCHD2, PARK7 |
regulation of transcription from RNA polymerase II promoter (GO:0006357) | 2.24 | 5 | SNCA, CHCHD2, PARK2, NR4A2, PARK7 |
transcription, DNA-templated (GO:0006351) | 1.91 | 5 | TBP, PARK2, NR4A2, ATXN3, CHCHD2 |
ubiquitin-dependent protein catabolic process (GO:0006511) | 3.72 | 5 | PARK2, ATXN3, UCHL1, FBXO7, PINK1 |
signaling (GO:0023052) | 3.25 | 5 | PARK2, PARK7, ATXN3, SNCA, FGF20 |
regulation of intrinsic apoptotic signaling pathway (GO:2001242) | 4.74 | 5 | PARK2, PARK7, LRRK2, HTRA2, PINK1 |
nucleobase-containing compound biosynthetic process (GO:0034654) | 1.72 | 5 | TBP, PARK2, CHCHD2, ATXN3, NR4A2 |
regulation of neurotransmitter levels (GO:0001505) | 4.77 | 5 | PARK7, SNCAIP, PARK2, SNCA, LRRK2 |
regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434) | 5.05 | 4 | GBA, PARK7, PARK2, LRRK2 |
regulation of homeostatic process (GO:0032844) | 3.65 | 4 | PLA2G6, LRRK2, PINK1, SNCA |
establishment of organelle localization (GO:0051656) | 4.15 | 4 | UCHL1, MAPT, SYNJ1, SNCA |
regulation of cell projection organization (GO:0031344) | 3.38 | 4 | PODXL, PARK2, MAPT, LRRK2 |
cellular macromolecule localization (GO:0070727) | 3.1 | 4 | PARK2, VPS13C, FBXO7, LRRK2 |
posttranscriptional regulation of gene expression (GO:0010608) | 3.64 | 4 | EIF4G1, GIGYF2, ATXN2, PINK1 |
cell projection morphogenesis (GO:0048858) | 4.05 | 4 | NR4A2, MAPT, UCHL1, LRRK2 |
regulation of neuron differentiation (GO:0045664) | 3.39 | 4 | EIF4G1, PARK2, MAPT, LRRK2 |
regulation of cellular amine metabolic process (GO:0033238) | 5.42 | 4 | NR4A2, PARK2, PARK7, SNCA |
positive regulation of cell development (GO:0010720) | 3.57 | 4 | EIF4G1, MAPT, PARK2, SYNJ1 |
cellular homeostasis (GO:0019725) | 3.23 | 4 | ATP13A2, PLA2G6, PARK2, LRRK2 |
protein catabolic process (GO:0030163) | 3.93 | 4 | PARK2, UCHL1, ATXN3, HTRA2 |
response to metal ion (GO:0010038) | 3.91 | 4 | ATP13A2, SNCA, PARK2, LRRK2 |
neurotransmitter transport (GO:0006836) | 5.07 | 4 | PARK7, PARK2, SYNJ1, SNCA |
cell motility (GO:0048870) | 3.02 | 4 | PODXL, MAPT, NR4A2, LRRK2 |
response to organonitrogen compound (GO:0010243) | 3.2 | 4 | NR4A2, PARK2, SNCA, LRRK2 |
anterograde trans-synaptic signaling (GO:0098916) | 3.98 | 4 | PARK2, PARK7, ATXN3, SNCA |
cellular component assembly (GO:0022607) | 2.14 | 4 | SYNJ1, PARK2, LRRK2, ATXN2 |
negative regulation of biosynthetic process (GO:0009890) | 2.47 | 4 | PARK2, NR4A2, GIGYF2, SNCA |
positive regulation of kinase activity (GO:0033674) | 3.54 | 4 | PARK7, LRRK2, PINK1, SNCA |
regulation of neurotransmitter transport (GO:0051588) | 5.55 | 4 | SNCAIP, PARK2, SNCA, LRRK2 |
regulation of protein secretion (GO:0050708) | 3.77 | 4 | ATP13A2, PLA2G6, PARK2, VPS35 |
macromolecular complex assembly (GO:0065003) | 2.55 | 4 | SYNJ1, PARK2, LRRK2, ATXN2 |
negative regulation of MAPK cascade (GO:0043409) | 4.74 | 4 | GBA, UCHL1, PARK2, PINK1 |
cell migration (GO:0016477) | 3.12 | 4 | PODXL, MAPT, NR4A2, LRRK2 |
response to cytokine (GO:0034097) | 3.84 | 4 | GBA, SNCA, SYNJ1, HTRA2 |
regulation of catecholamine metabolic process (GO:0042069) | 6.9 | 4 | NR4A2, PARK2, PARK7, SNCA |
catecholamine metabolic process (GO:0006584) | 6.02 | 4 | NR4A2, SNCAIP, PARK2, SNCA |
regulation of reactive oxygen species metabolic process (GO:2000377) | 4.71 | 4 | PARK7, PARK2, SNCA, PINK1 |
regulation of protein complex assembly (GO:0043254) | 3.83 | 4 | PARK7, MAPT, PINK1, SNCA |
response to nitrogen compound (GO:1901698) | 3.12 | 4 | NR4A2, PARK2, SNCA, LRRK2 |
cellular response to nitrogen compound (GO:1901699) | 3.79 | 4 | NR4A2, PARK2, SNCA, LRRK2 |
positive regulation of nervous system development (GO:0051962) | 3.64 | 4 | EIF4G1, MAPT, PARK2, SYNJ1 |
neuron projection morphogenesis (GO:0048812) | 4.34 | 4 | NR4A2, MAPT, UCHL1, LRRK2 |
presynaptic process involved in chemical synaptic transmission (GO:0099531) | 4.98 | 4 | PARK7, PARK2, SYNJ1, SNCA |
negative regulation of macromolecule biosynthetic process (GO:0010558) | 2.53 | 4 | PARK2, NR4A2, GIGYF2, SNCA |
synaptic signaling (GO:0099536) | 3.98 | 4 | PARK2, PARK7, ATXN3, SNCA |
trans-synaptic signaling (GO:0099537) | 3.98 | 4 | ATXN3, PARK7, PARK2, SNCA |
regulation of developmental growth (GO:0048638) | 4.04 | 4 | MAPT, PARK2, FGF20, HTRA2 |
catechol-containing compound metabolic process (GO:0009712) | 6.02 | 4 | NR4A2, PARK2, SNCAIP, SNCA |
cellular response to metal ion (GO:0071248) | 4.81 | 4 | ATP13A2, SNCA, PARK2, LRRK2 |
phosphorylation (GO:0016310) | 2.63 | 4 | ATP13A2, LRRK2, FGF20, PINK1 |
chemical synaptic transmission (GO:0007268) | 3.98 | 4 | PARK2, PARK7, ATXN3, SNCA |
cellular response to inorganic substance (GO:0071241) | 4.67 | 4 | ATP13A2, SNCA, PARK2, LRRK2 |
negative regulation of synaptic transmission (GO:0050805) | 5.67 | 4 | PLA2G6, PARK2, SNCA, LRRK2 |
regulation of protein targeting (GO:1903533) | 4.0 | 4 | PARK2, LRRK2, HTRA2, PINK1 |
response to organic cyclic compound (GO:0014070) | 3.07 | 4 | GBA, SNCA, PARK2, LRRK2 |
divalent inorganic cation homeostasis (GO:0072507) | 3.9 | 4 | ATP13A2, PLA2G6, PARK2, SNCA |
regulation of anatomical structure morphogenesis (GO:0022603) | 2.79 | 4 | MAPT, PARK2, LRRK2, PINK1 |
positive regulation of neurogenesis (GO:0050769) | 3.77 | 4 | EIF4G1, MAPT, PARK2, SYNJ1 |
regulation of protein modification by small protein conjugation or removal (GO:1903320) | 4.14 | 4 | PARK7, PARK2, LRRK2, PINK1 |
cell projection organization (GO:0030030) | 3.14 | 4 | NR4A2, MAPT, UCHL1, LRRK2 |
regulation of protein ubiquitination (GO:0031396) | 4.22 | 4 | PARK7, PARK2, LRRK2, PINK1 |
regulation of exocytosis (GO:0017157) | 4.59 | 4 | ATP13A2, PLA2G6, SNCA, LRRK2 |
cellular response to endogenous stimulus (GO:0071495) | 3.33 | 4 | NR4A2, PARK2, SNCA, LRRK2 |
phospholipid metabolic process (GO:0006644) | 3.88 | 4 | PLA2G6, SYNJ1, FGF20, SNCA |
positive regulation of cellular catabolic process (GO:0031331) | 4.15 | 4 | GBA, SNCA, PARK2, LRRK2 |
dopamine metabolic process (GO:0042417) | 6.51 | 4 | NR4A2, SNCAIP, PARK2, SNCA |
regulation of establishment of protein localization to mitochondrion (GO:1903747) | 4.88 | 4 | PARK2, LRRK2, HTRA2, PINK1 |
regulation of neurotransmitter secretion (GO:0046928) | 5.78 | 4 | SNCAIP, PARK2, SNCA, LRRK2 |
phenol-containing compound metabolic process (GO:0018958) | 5.33 | 4 | NR4A2, SNCAIP, PARK2, SNCA |
cell part morphogenesis (GO:0032990) | 3.99 | 4 | NR4A2, MAPT, UCHL1, LRRK2 |
positive regulation of transcription from RNA polymerase II promoter (GO:0045944) | 2.81 | 4 | CHCHD2, PARK2, NR4A2, PARK7 |
protein localization to organelle (GO:0033365) | 3.57 | 4 | FBXO7, VPS13C, PARK2, LRRK2 |
positive regulation of protein kinase activity (GO:0045860) | 3.61 | 4 | PARK7, LRRK2, PINK1, SNCA |
response to extracellular stimulus (GO:0009991) | 3.71 | 4 | GBA, NR4A2, MAPT, LRRK2 |
regulation of dopamine metabolic process (GO:0042053) | 6.9 | 4 | NR4A2, PARK2, PARK7, SNCA |
negative regulation of cellular biosynthetic process (GO:0031327) | 2.49 | 4 | NR4A2, PARK2, GIGYF2, SNCA |
response to transition metal nanoparticle (GO:1990267) | 4.7 | 4 | ATP13A2, SNCA, PARK2, LRRK2 |
protein transport (GO:0015031) | 2.62 | 4 | DNAJC13, VPS35, FBXO7, VPS13C |
negative regulation of mitochondrion organization (GO:0010823) | 6.07 | 4 | VPS13C, PARK2, LRRK2, PINK1 |
cell death (GO:0008219) | 3.05 | 4 | MAPT, LRRK2, SNCAIP, HTRA2 |
protein complex subunit organization (GO:0071822) | 2.6 | 4 | DNAJC6, PARK2, SYNJ1, LRRK2 |
positive regulation of protein catabolic process (GO:0045732) | 4.18 | 4 | GBA, ATXN3, PARK2, LRRK2 |
response to lipid (GO:0033993) | 3.11 | 4 | GBA, SYNJ1, SNCA, HTRA2 |
regulation of growth (GO:0040008) | 3.26 | 4 | MAPT, PARK2, FGF20, HTRA2 |
negative regulation of cellular macromolecule biosynthetic process (GO:2000113) | 2.6 | 4 | PARK2, NR4A2, GIGYF2, SNCA |
cellular component morphogenesis (GO:0032989) | 3.5 | 4 | NR4A2, MAPT, UCHL1, LRRK2 |
positive regulation of autophagy (GO:0010508) | 5.41 | 4 | GBA, PARK7, LRRK2, PINK1 |
negative regulation of autophagy (GO:0010507) | 5.76 | 4 | VPS13C, LRRK2, PINK1, SNCA |
protein phosphorylation (GO:0006468) | 2.89 | 4 | ATP13A2, FGF20, LRRK2, PINK1 |
negative regulation of protein kinase activity (GO:0006469) | 4.29 | 4 | GBA, PARK7, FBXO7, UCHL1 |
negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176) | 6.68 | 4 | PARK7, PARK2, HTRA2, PINK1 |
regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175) | 6.36 | 4 | PARK7, PARK2, HTRA2, PINK1 |
regulation of endopeptidase activity (GO:0052548) | 3.8 | 4 | ATP13A2, PARK7, SNCA, HTRA2 |
cellular protein localization (GO:0034613) | 3.11 | 4 | FBXO7, VPS13C, PARK2, LRRK2 |
reproductive process (GO:0022414) | 2.55 | 4 | TBP, PLA2G6, MAPT, PARK7 |
negative regulation of nitrogen compound metabolic process (GO:0051172) | 2.47 | 4 | NR4A2, PARK2, GIGYF2, SNCA |
metal ion homeostasis (GO:0055065) | 3.61 | 4 | ATP13A2, PLA2G6, PARK2, SNCA |
positive regulation of transferase activity (GO:0051347) | 3.31 | 4 | PARK7, LRRK2, PINK1, SNCA |
regulation of endocytosis (GO:0030100) | 4.42 | 4 | SYNJ1, DNAJC6, ATXN2, SNCA |
lipid biosynthetic process (GO:0008610) | 3.49 | 4 | GBA, PLA2G6, SYNJ1, FGF20 |
positive regulation of cell differentiation (GO:0045597) | 3.01 | 4 | EIF4G1, MAPT, PARK2, SYNJ1 |
regulation of mitochondrial membrane potential (GO:0051881) | 5.72 | 4 | PARK7, PARK2, LRRK2, PINK1 |
regulation of protein targeting to mitochondrion (GO:1903214) | 5.14 | 4 | PARK2, LRRK2, PINK1, HTRA2 |
regulation of synaptic vesicle transport (GO:1902803) | 6.29 | 4 | SNCA, PARK2, LRRK2, PINK1 |
regulation of translation (GO:0006417) | 3.96 | 4 | EIF4G1, GIGYF2, ATXN2, PINK1 |
single-organism cellular localization (GO:1902580) | 3.16 | 4 | SYNJ1, MAPT, UCHL1, SNCA |
cellular response to organonitrogen compound (GO:0071417) | 3.87 | 4 | NR4A2, PARK2, SNCA, LRRK2 |
axonogenesis (GO:0007409) | 4.74 | 3 | NR4A2, MAPT, UCHL1 |
catecholamine uptake involved in synaptic transmission (GO:0051934) | 8.12 | 3 | PARK7, PARK2, SNCA |
negative regulation of intracellular transport (GO:0032387) | 5.02 | 3 | PARK7, MAPT, LRRK2 |
cell development (GO:0048468) | 3.28 | 3 | PODXL, UCHL1, HTRA2 |
activation of protein kinase activity (GO:0032147) | 4.08 | 3 | PARK7, LRRK2, PINK1 |
learning or memory (GO:0007611) | 4.33 | 3 | PLA2G6, PARK2, SYNJ1 |
regulation of ATP metabolic process (GO:1903578) | 5.82 | 3 | PARK7, SNCA, PINK1 |
regulation of Wnt signaling pathway (GO:0030111) | 3.98 | 3 | VPS35, PARK2, LRRK2 |
protein autophosphorylation (GO:0046777) | 4.46 | 3 | ATP13A2, LRRK2, PINK1 |
calcium ion homeostasis (GO:0055074) | 3.97 | 3 | ATP13A2, PLA2G6, SNCA |
small molecule catabolic process (GO:0044282) | 3.99 | 3 | PARK7, GLUD2, SYNJ1 |
small molecule biosynthetic process (GO:0044283) | 3.79 | 3 | GBA, PARK7, GLUD2 |
response to manganese ion (GO:0010042) | 6.84 | 3 | ATP13A2, PARK2, LRRK2 |
negative regulation of response to endoplasmic reticulum stress (GO:1903573) | 6.07 | 3 | PARK7, PARK2, LRRK2 |
cell surface receptor signaling pathway involved in cell-cell signaling (GO:1905114) | 3.79 | 3 | NR4A2, VPS35, LRRK2 |
regulation of transmembrane transport (GO:0034762) | 3.74 | 3 | PLA2G6, PARK7, SNCA |
negative regulation of cell cycle (GO:0045786) | 3.67 | 3 | GIGYF2, FBXO7, HTRA2 |
regulation of cytoskeleton organization (GO:0051493) | 3.72 | 3 | MAPT, PARK2, SNCA |
interspecies interaction between organisms (GO:0044419) | 3.08 | 3 | TBP, EIF4G1, PARK2 |
protein modification by small protein conjugation (GO:0032446) | 3.1 | 3 | PARK2, FBXO7, PINK1 |
regulation of hydrogen peroxide-induced cell death (GO:1903205) | 6.78 | 3 | PARK7, LRRK2, PINK1 |
positive regulation of neuron differentiation (GO:0045666) | 3.98 | 3 | EIF4G1, PARK2, MAPT |
regulation of oxidative stress-induced neuron death (GO:1903203) | 7.33 | 3 | PARK7, PARK2, PINK1 |
regulation of amine transport (GO:0051952) | 5.62 | 3 | SNCA, PARK2, PINK1 |
regulation of mitochondrial electron transport, NADH to ubiquinone (GO:1902956) | 8.34 | 3 | PARK7, SNCA, PINK1 |
monoamine transport (GO:0015844) | 6.64 | 3 | PARK7, PARK2, SNCA |
regulation of neuron projection development (GO:0010975) | 3.69 | 3 | MAPT, PARK2, LRRK2 |
oxoacid metabolic process (GO:0043436) | 3.12 | 3 | PARK7, GLUD2, SNCA |
glycerolipid metabolic process (GO:0046486) | 3.91 | 3 | PLA2G6, SYNJ1, FGF20 |
dopamine transport (GO:0015872) | 7.33 | 3 | PARK7, PARK2, SNCA |
protein localization to mitochondrion (GO:0070585) | 5.74 | 3 | PARK2, FBXO7, LRRK2 |
cellular response to extracellular stimulus (GO:0031668) | 4.57 | 3 | GBA, NR4A2, LRRK2 |
single organism reproductive process (GO:0044702) | 2.73 | 3 | TBP, PLA2G6, PARK7 |
organic acid metabolic process (GO:0006082) | 3.01 | 3 | PARK7, GLUD2, SNCA |
cellular response to manganese ion (GO:0071287) | 7.43 | 3 | ATP13A2, PARK2, LRRK2 |
Wnt signaling pathway (GO:0016055) | 3.88 | 3 | NR4A2, VPS35, LRRK2 |
response to nutrient levels (GO:0031667) | 3.77 | 3 | GBA, MAPT, LRRK2 |
immune system process (GO:0002376) | 2.29 | 3 | PODXL, PLA2G6, SNCA |
protein ubiquitination (GO:0016567) | 3.28 | 3 | PARK2, FBXO7, PINK1 |
neurotransmitter uptake (GO:0001504) | 7.02 | 3 | PARK7, PARK2, SNCA |
negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903377) | 8.12 | 3 | PARK7, PARK2, PINK1 |
negative regulation of RNA metabolic process (GO:0051253) | 2.66 | 3 | NR4A2, PARK2, SNCA |
regulation of canonical Wnt signaling pathway (GO:0060828) | 4.26 | 3 | VPS35, PARK2, LRRK2 |
regulation of cell morphogenesis (GO:0022604) | 3.4 | 3 | MAPT, PARK2, LRRK2 |
organic hydroxy compound transport (GO:0015850) | 4.96 | 3 | PARK7, PARK2, SNCA |
regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235) | 6.33 | 3 | PARK7, PARK2, LRRK2 |
organelle disassembly (GO:1903008) | 4.52 | 3 | FBXO7, PARK2, PINK1 |
negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236) | 6.78 | 3 | PARK7, PARK2, LRRK2 |
protein stabilization (GO:0050821) | 4.86 | 3 | PARK7, PARK2, PINK1 |
dopamine uptake involved in synaptic transmission (GO:0051583) | 8.12 | 3 | PARK7, PARK2, SNCA |
response to monoamine (GO:0071867) | 6.17 | 3 | SNCA, PARK2, LRRK2 |
cellular response to monoamine stimulus (GO:0071868) | 6.29 | 3 | SNCA, PARK2, LRRK2 |
response to catecholamine (GO:0071869) | 6.23 | 3 | SNCA, PARK2, LRRK2 |
negative regulation of protein serine/threonine kinase activity (GO:0071901) | 4.92 | 3 | GBA, UCHL1, FBXO7 |
negative regulation of protein transport (GO:0051224) | 4.44 | 3 | PARK7, PARK2, LRRK2 |
regulation of cellular respiration (GO:0043457) | 6.68 | 3 | PARK7, SNCA, PINK1 |
regulation of oxidoreductase activity (GO:0051341) | 5.27 | 3 | PARK7, PARK2, SNCA |
negative regulation of hydrolase activity (GO:0051346) | 3.74 | 3 | PARK7, SNCA, LRRK2 |
intracellular protein transport (GO:0006886) | 3.2 | 3 | VPS35, FBXO7, VPS13C |
regulation of anatomical structure size (GO:0090066) | 3.78 | 3 | ATP13A2, PLA2G6, LRRK2 |
regulation of immune system process (GO:0002682) | 2.5 | 3 | PLA2G6, FBXO7, SNCA |
synaptic transmission, dopaminergic (GO:0001963) | 7.02 | 3 | PARK7, PARK2, SNCA |
dopamine uptake (GO:0090494) | 8.12 | 3 | PARK7, PARK2, SNCA |
catecholamine uptake (GO:0090493) | 8.12 | 3 | PARK7, PARK2, SNCA |
regulation of release of cytochrome c from mitochondria (GO:0090199) | 5.94 | 3 | PLA2G6, PARK2, PINK1 |
adult walking behavior (GO:0007628) | 6.23 | 3 | UCHL1, MAPT, HTRA2 |
defense response (GO:0006952) | 2.78 | 3 | PLA2G6, EIF4G1, PARK7 |
glycerophospholipid biosynthetic process (GO:0046474) | 4.62 | 3 | PLA2G6, SYNJ1, FGF20 |
regulation of receptor-mediated endocytosis (GO:0048259) | 5.35 | 3 | DNAJC6, SYNJ1, ATXN2 |
organophosphate biosynthetic process (GO:0090407) | 3.67 | 3 | PLA2G6, SYNJ1, FGF20 |
endocytosis (GO:0006897) | 3.69 | 3 | SYNJ1, SNCA, LRRK2 |
positive regulation of protein secretion (GO:0050714) | 4.39 | 3 | ATP13A2, PLA2G6, VPS35 |
cognition (GO:0050890) | 4.2 | 3 | PLA2G6, PARK2, SYNJ1 |
regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903376) | 7.78 | 3 | PARK7, PARK2, PINK1 |
cellular amide metabolic process (GO:0043603) | 3.23 | 3 | GBA, EIF4G1, HTRA2 |
organic hydroxy compound biosynthetic process (GO:1901617) | 4.98 | 3 | GBA, NR4A2, SNCA |
regulation of nucleotide metabolic process (GO:0006140) | 4.38 | 3 | PARK7, SNCA, PINK1 |
cellular response to catecholamine stimulus (GO:0071870) | 6.33 | 3 | SNCA, PARK2, LRRK2 |
regulation of MAP kinase activity (GO:0043405) | 3.95 | 3 | GBA, UCHL1, LRRK2 |
proteasomal protein catabolic process (GO:0010498) | 4.12 | 3 | PARK2, UCHL1, ATXN3 |
negative regulation of establishment of protein localization (GO:1904950) | 4.39 | 3 | PARK7, PARK2, LRRK2 |
regulation of catecholamine secretion (GO:0050433) | 5.99 | 3 | SNCA, PARK2, PINK1 |
positive regulation of cellular protein localization (GO:1903829) | 3.85 | 3 | PARK7, HTRA2, PINK1 |
positive regulation of peptidase activity (GO:0010952) | 4.7 | 3 | SNCA, HTRA2, PINK1 |
negative regulation of transcription from RNA polymerase II promoter (GO:0000122) | 3.12 | 3 | NR4A2, PARK2, SNCA |
proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161) | 4.16 | 3 | PARK2, UCHL1, ATXN3 |
positive regulation of protein modification by small protein conjugation or removal (GO:1903322) | 4.48 | 3 | PARK2, LRRK2, PINK1 |
regulation of transporter activity (GO:0032409) | 4.45 | 3 | PLA2G6, PARK7, SNCA |
negative regulation of oxidative stress-induced neuron death (GO:1903204) | 7.65 | 3 | PARK7, PARK2, PINK1 |
regulation of protein polymerization (GO:0032271) | 4.57 | 3 | MAPT, SNCA, PINK1 |
positive regulation of protein ubiquitination (GO:0031398) | 4.55 | 3 | PARK2, LRRK2, PINK1 |
cellular response to external stimulus (GO:0071496) | 4.2 | 3 | GBA, NR4A2, LRRK2 |
positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052) | 4.6 | 3 | GBA, PARK2, LRRK2 |
establishment of protein localization to organelle (GO:0072594) | 3.92 | 3 | VPS13C, FBXO7, PINK1 |
cellular ion homeostasis (GO:0006873) | 3.57 | 3 | ATP13A2, PLA2G6, LRRK2 |
negative regulation of nucleic acid-templated transcription (GO:1903507) | 2.71 | 3 | NR4A2, PARK2, SNCA |
cellular response to DNA damage stimulus (GO:0006974) | 3.17 | 3 | GIGYF2, ATXN3, HTRA2 |
regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281) | 4.43 | 3 | PARK7, SNCA, HTRA2 |
regulation of locomotion (GO:0040012) | 3.12 | 3 | PODXL, SNCA, LRRK2 |
negative regulation of transcription, DNA-templated (GO:0045892) | 2.75 | 3 | NR4A2, PARK2, SNCA |
cellular cation homeostasis (GO:0030003) | 3.6 | 3 | ATP13A2, PLA2G6, LRRK2 |
cellular chemical homeostasis (GO:0055082) | 3.4 | 3 | ATP13A2, PLA2G6, LRRK2 |
negative regulation of developmental process (GO:0051093) | 3.17 | 3 | PARK2, FBXO7, PINK1 |
vacuole organization (GO:0007033) | 4.67 | 3 | ATP13A2, DNAJC13, LRRK2 |
phospholipid biosynthetic process (GO:0008654) | 4.39 | 3 | PLA2G6, SYNJ1, FGF20 |
mitophagy (GO:0000422) | 4.63 | 3 | PARK2, FBXO7, PINK1 |
neurotransmitter reuptake (GO:0098810) | 7.53 | 3 | PARK7, PARK2, SNCA |
cellular response to organic cyclic compound (GO:0071407) | 3.93 | 3 | SNCA, PARK2, LRRK2 |
positive regulation of binding (GO:0051099) | 4.88 | 3 | PARK7, PARK2, LRRK2 |
regulation of binding (GO:0051098) | 4.08 | 3 | PARK7, PARK2, LRRK2 |
regulation of vacuolar transport (GO:1903335) | 6.36 | 3 | DNAJC13, VPS35, LRRK2 |
negative regulation of response to reactive oxygen species (GO:1901032) | 6.96 | 3 | PARK7, LRRK2, PINK1 |
regulation of response to reactive oxygen species (GO:1901031) | 6.29 | 3 | PARK7, LRRK2, PINK1 |
system development (GO:0048731) | 2.92 | 3 | PARK2, NR4A2, ATXN3 |
negative regulation of proteolysis (GO:0045861) | 3.98 | 3 | PARK7, SNCA, LRRK2 |
positive regulation of peptidyl-serine phosphorylation (GO:0033138) | 5.26 | 3 | PARK7, SNCA, PINK1 |
glycerophospholipid metabolic process (GO:0006650) | 4.13 | 3 | PLA2G6, SYNJ1, FGF20 |
regulation of peptidyl-serine phosphorylation (GO:0033135) | 4.98 | 3 | PARK7, SNCA, PINK1 |
cellular macromolecular complex assembly (GO:0034622) | 3.18 | 3 | SYNJ1, PARK2, ATXN2 |
carboxylic acid metabolic process (GO:0019752) | 3.12 | 3 | PARK7, GLUD2, SNCA |
negative regulation of hydrogen peroxide-induced cell death (GO:1903206) | 6.96 | 3 | PARK7, LRRK2, PINK1 |
regulation of oxidative phosphorylation (GO:0002082) | 6.96 | 3 | PARK7, SNCA, PINK1 |
neuromuscular process (GO:0050905) | 5.27 | 3 | UCHL1, PARK2, GIGYF2 |
neuron-neuron synaptic transmission (GO:0007270) | 5.74 | 3 | PARK7, PARK2, SNCA |
regulation of dopamine secretion (GO:0014059) | 6.64 | 3 | SNCA, PARK2, PINK1 |
regulation of ion transport (GO:0043269) | 3.4 | 3 | PLA2G6, PARK7, SNCA |
regulation of purine nucleotide metabolic process (GO:1900542) | 4.41 | 3 | PARK7, SNCA, PINK1 |
glycerolipid biosynthetic process (GO:0045017) | 4.53 | 3 | PLA2G6, SYNJ1, FGF20 |
regulation of generation of precursor metabolites and energy (GO:0043467) | 5.24 | 3 | PARK7, SNCA, PINK1 |
regulation of cysteine-type endopeptidase activity (GO:2000116) | 4.37 | 3 | PARK7, SNCA, HTRA2 |
regulation of mitochondrial fission (GO:0090140) | 6.84 | 3 | PARK2, LRRK2, PINK1 |
response to toxic substance (GO:0009636) | 4.88 | 3 | PARK2, HTRA2, PINK1 |
catecholamine transport (GO:0051937) | 7.09 | 3 | PARK7, PARK2, SNCA |
regulation of organelle assembly (GO:1902115) | 4.7 | 3 | LRRK2, ATXN2, PINK1 |
negative regulation of macroautophagy (GO:0016242) | 6.68 | 3 | VPS13C, LRRK2, PINK1 |
positive regulation of cellular protein catabolic process (GO:1903364) | 4.52 | 3 | GBA, PARK2, LRRK2 |
negative regulation of nucleobase-containing compound metabolic process (GO:0045934) | 2.55 | 3 | NR4A2, PARK2, SNCA |
neuron differentiation (GO:0030182) | 4.17 | 3 | NR4A2, GIGYF2, FGF20 |
mitochondrion disassembly (GO:0061726) | 4.63 | 3 | PARK2, FBXO7, PINK1 |
protein complex assembly (GO:0006461) | 2.78 | 3 | SYNJ1, PARK2, LRRK2 |
negative regulation of RNA biosynthetic process (GO:1902679) | 2.7 | 3 | NR4A2, PARK2, SNCA |
multi-organism cellular process (GO:0044764) | 3.14 | 3 | TBP, EIF4G1, PARK2 |
import into cell (GO:0098657) | 6.12 | 3 | PARK7, PARK2, SNCA |
mitochondrion localization (GO:0051646) | 6.15 | 3 | UCHL1, MAPT, LRRK2 |
regulation of nucleoside metabolic process (GO:0009118) | 5.82 | 3 | PARK7, SNCA, PINK1 |
positive regulation of ion transport (GO:0043270) | 4.36 | 3 | PLA2G6, PARK7, SNCA |
microtubule-based process (GO:0007017) | 3.54 | 3 | UCHL1, ATXN3, MAPT |
regulation of cell cycle (GO:0051726) | 2.93 | 3 | GIGYF2, FBXO7, HTRA2 |
walking behavior (GO:0090659) | 6.23 | 3 | UCHL1, MAPT, HTRA2 |
alcohol metabolic process (GO:0006066) | 4.2 | 3 | GBA, SYNJ1, ADH1C |
viral process (GO:0016032) | 3.15 | 3 | TBP, EIF4G1, PARK2 |
symbiosis, encompassing mutualism through parasitism (GO:0044403) | 3.15 | 3 | TBP, EIF4G1, PARK2 |
regulation of vacuole organization (GO:0044088) | 6.02 | 3 | SYNJ1, LRRK2, PINK1 |
regulation of peptide transport (GO:0090087) | 4.37 | 2 | PLA2G6, PARK2 |
regulation of chaperone-mediated autophagy (GO:1904714) | 7.78 | 2 | ATP13A2, SNCA |
regulation of extrinsic apoptotic signaling pathway (GO:2001236) | 4.69 | 2 | PARK7, HTRA2 |
response to growth factor (GO:0070848) | 4.14 | 2 | SNCA, HTRA2 |
positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436) | 5.47 | 2 | PARK2, LRRK2 |
developmental growth (GO:0048589) | 4.05 | 2 | MAPT, GIGYF2 |
anatomical structure homeostasis (GO:0060249) | 4.25 | 2 | GIGYF2, PARK2 |
negative regulation of secretion (GO:0051048) | 4.44 | 2 | SNCA, PARK2 |
cellular response to heat (GO:0034605) | 6.17 | 2 | ATXN3, HTRA2 |
learning (GO:0007612) | 4.85 | 2 | SYNJ1, PARK2 |
activation of protein kinase B activity (GO:0032148) | 6.51 | 2 | PARK7, PINK1 |
mitophagy in response to mitochondrial depolarization (GO:0098779) | 4.85 | 2 | PARK2, PINK1 |
regulation of G-protein coupled receptor protein signaling pathway (GO:0008277) | 4.97 | 2 | SNCA, LRRK2 |
positive regulation of cellular respiration (GO:1901857) | 8.34 | 2 | PARK7, PINK1 |
protein complex disassembly (GO:0043241) | 4.58 | 2 | DNAJC6, SYNJ1 |
enzyme linked receptor protein signaling pathway (GO:0007167) | 3.24 | 2 | GIGYF2, FGF20 |
positive regulation of transmembrane transport (GO:0034764) | 4.99 | 2 | PARK7, SNCA |
transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169) | 3.54 | 2 | GIGYF2, FGF20 |
lipid catabolic process (GO:0016042) | 4.21 | 2 | GBA, PLA2G6 |
maintenance of location in cell (GO:0051651) | 5.13 | 2 | VPS13C, PINK1 |
establishment of vesicle localization (GO:0051650) | 4.91 | 2 | SYNJ1, SNCA |
regulation of defense response (GO:0031347) | 3.11 | 2 | GBA, PARK7 |
positive regulation of cell projection organization (GO:0031346) | 3.99 | 2 | MAPT, PARK2 |
regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267) | 6.64 | 2 | PARK7, HTRA2 |
regulation of hydrogen peroxide metabolic process (GO:0010310) | 7.02 | 2 | SNCA, PINK1 |
negative regulation of G1/S transition of mitotic cell cycle (GO:2000134) | 5.17 | 2 | GIGYF2, FBXO7 |
response to external biotic stimulus (GO:0043207) | 3.13 | 2 | PLA2G6, SNCA |
negative regulation of cytoskeleton organization (GO:0051494) | 5.01 | 2 | SNCA, PARK2 |
MAPK cascade (GO:0000165) | 3.91 | 2 | LRRK2, FGF20 |
protein modification by small protein removal (GO:0070646) | 4.83 | 2 | UCHL1, ATXN3 |
regulation of cytokine production (GO:0001817) | 3.4 | 2 | GBA, PARK7 |
regulation of hydrogen peroxide-induced neuron death (GO:1903207) | 8.34 | 2 | PARK7, PINK1 |
electron transport chain (GO:0022900) | 5.09 | 2 | SNCA, PINK1 |
positive regulation of release of cytochrome c from mitochondria (GO:0090200) | 6.4 | 2 | PLA2G6, PINK1 |
respiratory electron transport chain (GO:0022904) | 5.11 | 2 | SNCA, PINK1 |
regulation of signal transduction by p53 class mediator (GO:1901796) | 4.63 | 2 | TBP, PARK2 |
synaptic vesicle localization (GO:0097479) | 5.31 | 2 | SYNJ1, SNCA |
positive regulation of establishment of protein localization to mitochondrion (GO:1903749) | 4.98 | 2 | HTRA2, PINK1 |
regulation of cell morphogenesis involved in differentiation (GO:0010769) | 3.91 | 2 | MAPT, LRRK2 |
sphingolipid metabolic process (GO:0006665) | 4.79 | 2 | GBA, HTRA2 |
regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122) | 4.27 | 2 | PARK2, PINK1 |
positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123) | 4.54 | 2 | PARK2, PINK1 |
regulation of cell proliferation (GO:0042127) | 2.41 | 2 | LRRK2, FGF20 |
positive regulation of proteasomal protein catabolic process (GO:1901800) | 5.29 | 2 | PARK2, LRRK2 |
clathrin-mediated endocytosis (GO:0072583) | 6.15 | 2 | SYNJ1, SNCA |
regulation of microtubule polymerization (GO:0031113) | 6.4 | 2 | MAPT, SNCA |
maintenance of protein location (GO:0045185) | 5.21 | 2 | VPS13C, PINK1 |
positive regulation of protein targeting to mitochondrion (GO:1903955) | 5.26 | 2 | HTRA2, PINK1 |
establishment of localization by movement along microtubule (GO:0010970) | 5.14 | 2 | UCHL1, MAPT |
phosphatidylinositol metabolic process (GO:0046488) | 4.46 | 2 | SYNJ1, FGF20 |
regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway (GO:1903383) | 9.04 | 2 | PARK7, PINK1 |
establishment of protein localization to mitochondrion (GO:0072655) | 5.63 | 2 | FBXO7, PINK1 |
peptidyl-serine modification (GO:0018209) | 4.72 | 2 | LRRK2, PINK1 |
establishment of synaptic vesicle localization (GO:0097480) | 5.33 | 2 | SYNJ1, SNCA |
endosomal transport (GO:0016197) | 4.28 | 2 | VPS35, VPS13C |
post-embryonic development (GO:0009791) | 5.35 | 2 | NR4A2, GIGYF2 |
regulation of synaptic transmission, dopaminergic (GO:0032225) | 6.9 | 2 | SNCA, PINK1 |
cellular response to nutrient levels (GO:0031669) | 4.7 | 2 | GBA, LRRK2 |
response to biotic stimulus (GO:0009607) | 3.09 | 2 | PLA2G6, SNCA |
organonitrogen compound catabolic process (GO:1901565) | 3.91 | 2 | GBA, GLUD2 |
negative regulation of oxidoreductase activity (GO:0051354) | 6.51 | 2 | SNCA, PARK2 |
regulation of late endosome to lysosome transport (GO:1902822) | 8.34 | 2 | VPS35, LRRK2 |
negative regulation of late endosome to lysosome transport (GO:1902823) | 9.04 | 2 | VPS35, LRRK2 |
organic acid biosynthetic process (GO:0016053) | 4.26 | 2 | PARK7, GLUD2 |
positive regulation of oxidoreductase activity (GO:0051353) | 5.94 | 2 | PARK7, SNCA |
negative regulation of protein catabolic process (GO:0042177) | 5.24 | 2 | ATP13A2, PARK7 |
positive regulation of oxidative phosphorylation (GO:1903862) | 7.94 | 2 | PARK7, PINK1 |
multicellular organismal response to stress (GO:0033555) | 5.67 | 2 | NR4A2, EIF4G1 |
negative regulation of mitotic cell cycle phase transition (GO:1901991) | 4.82 | 2 | GIGYF2, FBXO7 |
regulation of microtubule cytoskeleton organization (GO:0070507) | 4.98 | 2 | MAPT, SNCA |
ceramide metabolic process (GO:0006672) | 5.41 | 2 | GBA, HTRA2 |
negative regulation of mitophagy (GO:1903147) | 8.34 | 2 | VPS13C, PINK1 |
feeding behavior (GO:0007631) | 5.21 | 2 | UCHL1, GIGYF2 |
positive regulation of homeostatic process (GO:0032846) | 4.38 | 2 | PLA2G6, SNCA |
negative regulation of catabolic process (GO:0009895) | 4.81 | 2 | ATP13A2, PARK7 |
positive regulation of canonical Wnt signaling pathway (GO:0090263) | 4.95 | 2 | VPS35, LRRK2 |
regulation of cation transmembrane transport (GO:1904062) | 4.4 | 2 | PLA2G6, SNCA |
transition metal ion homeostasis (GO:0055076) | 5.09 | 2 | ATP13A2, PARK2 |
regulation of DNA binding (GO:0051101) | 5.21 | 2 | PARK7, PARK2 |
negative regulation of binding (GO:0051100) | 4.85 | 2 | PARK7, LRRK2 |
positive regulation of cellular response to oxidative stress (GO:1900409) | 7.16 | 2 | PARK7, PARK2 |
regulation of neurotransmitter uptake (GO:0051580) | 7.02 | 2 | SNCA, PARK2 |
positive regulation of Wnt signaling pathway (GO:0030177) | 4.7 | 2 | VPS35, LRRK2 |
neuron migration (GO:0001764) | 5.0 | 2 | NR4A2, MAPT |
establishment of mitochondrion localization (GO:0051654) | 6.9 | 2 | UCHL1, MAPT |
positive regulation of DNA binding (GO:0043388) | 6.02 | 2 | PARK7, PARK2 |
positive regulation of protein serine/threonine kinase activity (GO:0071902) | 4.06 | 2 | SNCA, LRRK2 |
catecholamine biosynthetic process (GO:0042423) | 6.9 | 2 | NR4A2, SNCA |
establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 7.02 | 2 | UCHL1, MAPT |
synaptic vesicle transport (GO:0048489) | 5.33 | 2 | SYNJ1, SNCA |
negative regulation of protein binding (GO:0032091) | 5.36 | 2 | PARK7, LRRK2 |
regulation of mitotic cell cycle (GO:0007346) | 3.71 | 2 | GIGYF2, FBXO7 |
positive regulation of GTPase activity (GO:0043547) | 3.28 | 2 | LRRK2, FGF20 |
negative regulation of vacuolar transport (GO:1903336) | 8.34 | 2 | VPS35, LRRK2 |
positive regulation of protein kinase B signaling (GO:0051897) | 5.32 | 2 | PARK7, PINK1 |
negative regulation of cellular protein catabolic process (GO:1903363) | 5.92 | 2 | ATP13A2, PARK7 |
positive regulation of nucleotide metabolic process (GO:0045981) | 4.85 | 2 | PARK7, PINK1 |
cellular response to topologically incorrect protein (GO:0035967) | 7.43 | 2 | PARK2, ATXN3 |
axo-dendritic transport (GO:0008088) | 6.12 | 2 | UCHL1, MAPT |
regulation of protein kinase B signaling (GO:0051896) | 4.92 | 2 | PARK7, PINK1 |
exploration behavior (GO:0035640) | 6.55 | 2 | ATXN3, LRRK2 |
signal transduction by protein phosphorylation (GO:0023014) | 3.79 | 2 | LRRK2, FGF20 |
transcription initiation from RNA polymerase II promoter (GO:0006367) | 4.7 | 2 | TBP, NR4A2 |
transcription from RNA polymerase II promoter (GO:0006366) | 3.38 | 2 | TBP, NR4A2 |
positive regulation of intracellular transport (GO:0032388) | 4.08 | 2 | HTRA2, PINK1 |
protein deubiquitination (GO:0016579) | 4.97 | 2 | UCHL1, ATXN3 |
negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway (GO:1903384) | 9.04 | 2 | PARK7, PINK1 |
negative regulation of reactive oxygen species metabolic process (GO:2000378) | 5.99 | 2 | PARK2, PINK1 |
positive regulation of reactive oxygen species metabolic process (GO:2000379) | 5.29 | 2 | PARK7, SNCA |
regulation of monooxygenase activity (GO:0032768) | 5.69 | 2 | PARK7, SNCA |
regulation of insulin secretion (GO:0050796) | 4.57 | 2 | PLA2G6, PARK2 |
vesicle localization (GO:0051648) | 4.85 | 2 | SYNJ1, SNCA |
positive regulation of intracellular protein transport (GO:0090316) | 4.19 | 2 | HTRA2, PINK1 |
positive regulation of MAPK cascade (GO:0043410) | 3.57 | 2 | LRRK2, FGF20 |
canonical Wnt signaling pathway (GO:0060070) | 5.26 | 2 | NR4A2, LRRK2 |
negative regulation of protein acetylation (GO:1901984) | 6.73 | 2 | PARK7, SNCA |
regulation of protein binding (GO:0043393) | 4.6 | 2 | PARK7, LRRK2 |
regulation of protein acetylation (GO:1901983) | 5.59 | 2 | PARK7, SNCA |
cellular response to starvation (GO:0009267) | 4.98 | 2 | GBA, LRRK2 |
response to temperature stimulus (GO:0009266) | 4.71 | 2 | ATXN3, HTRA2 |
excitatory postsynaptic potential (GO:0060079) | 6.43 | 2 | SNCA, LRRK2 |
regulation of postsynaptic membrane potential (GO:0060078) | 5.72 | 2 | SNCA, LRRK2 |
maintenance of location (GO:0051235) | 4.77 | 2 | VPS13C, PINK1 |
negative regulation of peptidase activity (GO:0010466) | 4.22 | 2 | PARK7, SNCA |
positive regulation of protein dephosphorylation (GO:0035307) | 6.26 | 2 | GBA, PINK1 |
positive regulation of dephosphorylation (GO:0035306) | 5.92 | 2 | GBA, PINK1 |
zinc ion homeostasis (GO:0055069) | 6.78 | 2 | ATP13A2, PARK2 |
regulation of ion transmembrane transport (GO:0034765) | 3.77 | 2 | PLA2G6, SNCA |
brain development (GO:0007420) | 4.24 | 2 | SYNJ1, MAPT |
regulation of lipid transport (GO:0032368) | 5.21 | 2 | PLA2G6, PARK2 |
programmed cell death (GO:0012501) | 3.1 | 2 | MAPT, HTRA2 |
carboxylic acid biosynthetic process (GO:0046394) | 4.32 | 2 | PARK7, GLUD2 |
regulation of transmembrane transporter activity (GO:0022898) | 4.52 | 2 | PLA2G6, PARK7 |
receptor-mediated endocytosis (GO:0006898) | 4.31 | 2 | SYNJ1, SNCA |
organelle transport along microtubule (GO:0072384) | 5.63 | 2 | UCHL1, MAPT |
regulation of leukocyte activation (GO:0002694) | 3.6 | 2 | SNCA, FBXO7 |
regulation of synaptic transmission, glutamatergic (GO:0051966) | 5.82 | 2 | PLA2G6, LRRK2 |
DNA-templated transcription, initiation (GO:0006352) | 4.49 | 2 | TBP, NR4A2 |
monocarboxylic acid metabolic process (GO:0032787) | 3.57 | 2 | PARK7, SNCA |
response to endoplasmic reticulum stress (GO:0034976) | 4.46 | 2 | PLA2G6, PARK2 |
regulation of carbohydrate metabolic process (GO:0006109) | 4.57 | 2 | SNCA, PARK2 |
catechol-containing compound biosynthetic process (GO:0009713) | 6.9 | 2 | NR4A2, SNCA |
regulation of hydrogen peroxide-mediated programmed cell death (GO:1901298) | 7.65 | 2 | PARK7, PINK1 |
negative regulation of hydrogen peroxide-mediated programmed cell death (GO:1901299) | 7.94 | 2 | PARK7, PINK1 |
positive regulation of developmental growth (GO:0048639) | 4.67 | 2 | MAPT, PARK2 |
synapse organization (GO:0050808) | 4.87 | 2 | SNCA, LRRK2 |
regulation of autophagosome assembly (GO:2000785) | 6.2 | 2 | LRRK2, PINK1 |
regulation of response to external stimulus (GO:0032101) | 3.06 | 2 | GBA, PARK7 |
dephosphorylation (GO:0016311) | 4.06 | 2 | DNAJC6, SYNJ1 |
positive regulation of cell growth (GO:0030307) | 4.73 | 2 | MAPT, PARK2 |
regulation of cell adhesion (GO:0030155) | 3.27 | 2 | PODXL, ATXN3 |
(GO:0099003) | 5.51 | 2 | SYNJ1, SNCA |
positive regulation of synaptic transmission (GO:0050806) | 5.07 | 2 | SNCA, PINK1 |
regulation of inflammatory response (GO:0050727) | 4.03 | 2 | GBA, PARK7 |
negative regulation of MAP kinase activity (GO:0043407) | 5.42 | 2 | GBA, UCHL1 |
positive regulation of exocytosis (GO:0045921) | 5.41 | 2 | ATP13A2, PLA2G6 |
negative regulation of secretion by cell (GO:1903531) | 4.55 | 2 | SNCA, PARK2 |
regulation of mitotic cell cycle phase transition (GO:1901990) | 4.23 | 2 | GIGYF2, FBXO7 |
regulation of microtubule-based process (GO:0032886) | 4.79 | 2 | MAPT, SNCA |
response to hypoxia (GO:0001666) | 4.13 | 2 | NR4A2, PINK1 |
regulation of GTPase activity (GO:0043087) | 3.21 | 2 | LRRK2, FGF20 |
regulation of dephosphorylation (GO:0035303) | 4.67 | 2 | GBA, PINK1 |
vesicle uncoating (GO:0072319) | 8.34 | 2 | DNAJC6, SYNJ1 |
negative regulation of cellular protein localization (GO:1903828) | 4.82 | 2 | PARK7, LRRK2 |
small GTPase mediated signal transduction (GO:0007264) | 3.85 | 2 | PARK7, LRRK2 |
cellular divalent inorganic cation homeostasis (GO:0072503) | 3.96 | 2 | ATP13A2, PLA2G6 |
protein targeting (GO:0006605) | 4.08 | 2 | VPS13C, FBXO7 |
mitochondrion transport along microtubule (GO:0047497) | 7.02 | 2 | UCHL1, MAPT |
regulation of cell cycle process (GO:0010564) | 3.5 | 2 | GIGYF2, FBXO7 |
cytoskeleton-dependent intracellular transport (GO:0030705) | 4.96 | 2 | UCHL1, MAPT |
animal organ development (GO:0048513) | 2.53 | 2 | SYNJ1, MAPT |
positive regulation of nucleoside metabolic process (GO:0045979) | 6.55 | 2 | PARK7, PINK1 |
negative regulation of cell cycle phase transition (GO:1901988) | 4.74 | 2 | GIGYF2, FBXO7 |
positive regulation of protein polymerization (GO:0032273) | 5.24 | 2 | MAPT, PINK1 |
positive regulation of intrinsic apoptotic signaling pathway (GO:2001244) | 5.76 | 2 | PARK7, PARK2 |
regulation of cell cycle phase transition (GO:1901987) | 4.15 | 2 | GIGYF2, FBXO7 |
cellular response to toxic substance (GO:0097237) | 7.53 | 2 | PARK2, PINK1 |
central nervous system neuron differentiation (GO:0021953) | 5.17 | 2 | NR4A2, GIGYF2 |
membrane lipid metabolic process (GO:0006643) | 4.51 | 2 | GBA, HTRA2 |
cellular metal ion homeostasis (GO:0006875) | 3.75 | 2 | ATP13A2, PLA2G6 |
macroautophagy (GO:0016236) | 4.3 | 2 | PARK2, PINK1 |
negative regulation of protein complex assembly (GO:0031333) | 5.07 | 2 | PARK7, SNCA |
positive regulation of protein complex assembly (GO:0031334) | 4.44 | 2 | MAPT, PINK1 |
regulation of cellular response to hypoxia (GO:1900037) | 7.33 | 2 | CHCHD2, PINK1 |
reactive oxygen species metabolic process (GO:0072593) | 5.14 | 2 | PARK7, LRRK2 |
regulation of stress-activated MAPK cascade (GO:0032872) | 4.45 | 2 | PARK2, PINK1 |
dopamine biosynthetic process (GO:0042416) | 7.43 | 2 | NR4A2, SNCA |
regulation of cell growth (GO:0001558) | 3.75 | 2 | MAPT, PARK2 |
positive regulation of neurotransmitter transport (GO:0051590) | 6.96 | 2 | SNCA, PARK2 |
response to acid chemical (GO:0001101) | 4.05 | 2 | SYNJ1, HTRA2 |
phosphatidylinositol biosynthetic process (GO:0006661) | 4.94 | 2 | SYNJ1, FGF20 |
cellular protein catabolic process (GO:0044257) | 6.51 | 2 | PARK2, HTRA2 |
response to heat (GO:0009408) | 5.24 | 2 | ATXN3, HTRA2 |
intrinsic apoptotic signaling pathway (GO:0097193) | 4.69 | 2 | MAPT, HTRA2 |
lipid modification (GO:0030258) | 4.37 | 2 | SYNJ1, FGF20 |
cytosolic transport (GO:0016482) | 4.98 | 2 | VPS35, VPS13C |
amide biosynthetic process (GO:0043604) | 3.6 | 2 | GBA, EIF4G1 |
positive regulation of sequence-specific DNA binding transcription factor activity (GO:0051091) | 4.29 | 2 | PARK7, PINK1 |
regulation of sequence-specific DNA binding transcription factor activity (GO:0051090) | 3.83 | 2 | PARK7, PINK1 |
cellular response to growth factor stimulus (GO:0071363) | 4.27 | 2 | SNCA, HTRA2 |
regulation of G1/S transition of mitotic cell cycle (GO:2000045) | 4.81 | 2 | GIGYF2, FBXO7 |
vacuolar transport (GO:0007034) | 4.18 | 2 | VPS35, VPS13C |
macromitophagy (GO:0000423) | 4.85 | 2 | PARK2, PINK1 |
response to hormone (GO:0009725) | 3.33 | 2 | GBA, NR4A2 |
carbohydrate derivative metabolic process (GO:1901135) | 3.07 | 2 | GBA, LRRK2 |
response to drug (GO:0042493) | 3.71 | 2 | PARK7, SNCA |
negative regulation of autophagosome assembly (GO:1902902) | 7.43 | 2 | LRRK2, PINK1 |
negative regulation of stress-activated protein kinase signaling cascade (GO:0070303) | 6.02 | 2 | PARK2, PINK1 |
cellular response to cytokine stimulus (GO:0071345) | 4.33 | 2 | GBA, HTRA2 |
regulation of protein dephosphorylation (GO:0035304) | 5.31 | 2 | GBA, PINK1 |
response to topologically incorrect protein (GO:0035966) | 5.45 | 2 | PARK2, ATXN3 |
positive regulation of oxidative stress-induced cell death (GO:1903209) | 7.33 | 2 | PARK7, PARK2 |
response to decreased oxygen levels (GO:0036293) | 4.09 | 2 | NR4A2, PINK1 |
microtubule cytoskeleton organization (GO:0000226) | 4.13 | 2 | MAPT, ATXN3 |
negative regulation of hydrogen peroxide-induced neuron death (GO:1903208) | 8.34 | 2 | PARK7, PINK1 |
regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide (GO:1903750) | 8.34 | 2 | PARK7, PINK1 |
cellular response to dopamine (GO:1903351) | 7.53 | 2 | PARK2, LRRK2 |
response to dopamine (GO:1903350) | 7.53 | 2 | PARK2, LRRK2 |
peptidyl-serine phosphorylation (GO:0018105) | 4.82 | 2 | LRRK2, PINK1 |
positive regulation of growth (GO:0045927) | 4.25 | 2 | MAPT, PARK2 |
maintenance of protein location in cell (GO:0032507) | 5.27 | 2 | VPS13C, PINK1 |
regulation of cell activation (GO:0050865) | 3.53 | 2 | SNCA, FBXO7 |
regulation of cellular carbohydrate metabolic process (GO:0010675) | 4.81 | 2 | SNCA, PARK2 |
apoptotic signaling pathway (GO:0097190) | 4.12 | 2 | MAPT, HTRA2 |
polyol metabolic process (GO:0019751) | 5.17 | 2 | GBA, SYNJ1 |
positive regulation of cysteine-type endopeptidase activity (GO:2001056) | 4.88 | 2 | SNCA, HTRA2 |
regulation of calcium ion transmembrane transport (GO:1903169) | 4.98 | 2 | PLA2G6, SNCA |
negative regulation of JNK cascade (GO:0046329) | 6.23 | 2 | PARK2, PINK1 |
negative regulation of cell cycle process (GO:0010948) | 4.37 | 2 | GIGYF2, FBXO7 |
negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide (GO:1903751) | 8.34 | 2 | PARK7, PINK1 |
regulation of ubiquitin-protein transferase activity (GO:0051438) | 4.98 | 2 | PARK7, PINK1 |
response to starvation (GO:0042594) | 4.69 | 2 | GBA, LRRK2 |
regulation of JNK cascade (GO:0046328) | 4.65 | 2 | PARK2, PINK1 |
negative regulation of neurotransmitter transport (GO:0051589) | 6.96 | 2 | SNCA, PARK2 |
regulation of anion transport (GO:0044070) | 5.25 | 2 | PLA2G6, SNCA |
negative regulation of multicellular organismal process (GO:0051241) | 2.84 | 2 | GBA, FBXO7 |
generation of precursor metabolites and energy (GO:0006091) | 4.07 | 2 | SNCA, PINK1 |
multicellular organismal reproductive process (GO:0048609) | 3.35 | 2 | TBP, PLA2G6 |
macromolecular complex disassembly (GO:0032984) | 4.53 | 2 | DNAJC6, SYNJ1 |
growth (GO:0040007) | 3.8 | 2 | MAPT, GIGYF2 |
negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154) | 5.29 | 2 | PARK7, SNCA |
negative regulation of cysteine-type endopeptidase activity (GO:2000117) | 5.25 | 2 | PARK7, SNCA |
protein destabilization (GO:0031648) | 6.2 | 2 | SNCA, PARK2 |
positive regulation of mitochondrial fission (GO:0090141) | 7.09 | 2 | PARK2, PINK1 |
protein depolymerization (GO:0051261) | 6.47 | 2 | DNAJC6, SYNJ1 |
positive regulation of ATP metabolic process (GO:1903580) | 6.55 | 2 | PARK7, PINK1 |
negative regulation of cellular catabolic process (GO:0031330) | 5.38 | 2 | ATP13A2, PARK7 |
regulation of ion homeostasis (GO:2000021) | 4.44 | 2 | SNCA, LRRK2 |
synaptic vesicle endocytosis (GO:0048488) | 6.84 | 2 | SYNJ1, SNCA |
negative regulation of organelle assembly (GO:1902116) | 6.51 | 2 | LRRK2, PINK1 |
cellular calcium ion homeostasis (GO:0006874) | 4.01 | 2 | ATP13A2, PLA2G6 |
positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280) | 4.96 | 2 | SNCA, HTRA2 |
positive regulation of macroautophagy (GO:0016239) | 6.07 | 2 | GBA, PINK1 |
regulation of reactive oxygen species biosynthetic process (GO:1903426) | 5.55 | 2 | PARK7, SNCA |
negative regulation of mitotic cell cycle (GO:0045930) | 4.45 | 2 | GIGYF2, FBXO7 |
response to retinoic acid (GO:0032526) | 5.02 | 2 | SYNJ1, HTRA2 |
positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902177) | 7.78 | 2 | PARK7, PARK2 |
regulation of lipid metabolic process (GO:0019216) | 4.08 | 2 | PLA2G6, SNCA |
phenol-containing compound biosynthetic process (GO:0046189) | 6.26 | 2 | NR4A2, SNCA |
apoptotic process (GO:0006915) | 3.14 | 2 | MAPT, HTRA2 |
negative regulation of intracellular protein transport (GO:0090317) | 5.23 | 2 | PARK7, LRRK2 |
positive regulation of protein binding (GO:0032092) | 5.42 | 2 | PARK7, LRRK2 |
positive regulation of cellular amide metabolic process (GO:0034250) | 5.0 | 2 | PLA2G6, PINK1 |
regulation of hormone levels (GO:0010817) | 3.56 | 2 | PLA2G6, PARK2 |
regulation of metal ion transport (GO:0010959) | 3.94 | 2 | PLA2G6, SNCA |
phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 5.84 | 2 | SYNJ1, FGF20 |
regulation of stress-activated protein kinase signaling cascade (GO:0070302) | 4.44 | 2 | PARK2, PINK1 |
negative regulation of endopeptidase activity (GO:0010951) | 4.26 | 2 | PARK7, SNCA |
positive regulation of endopeptidase activity (GO:0010950) | 4.78 | 2 | SNCA, HTRA2 |
positive regulation of response to oxidative stress (GO:1902884) | 7.09 | 2 | PARK7, PARK2 |
cellular protein complex disassembly (GO:0043624) | 4.92 | 2 | DNAJC6, SYNJ1 |
cellular protein complex assembly (GO:0043623) | 3.9 | 2 | SYNJ1, PARK2 |
response to oxygen levels (GO:0070482) | 4.02 | 2 | NR4A2, PINK1 |
regulation of cellular component movement (GO:0051270) | 3.08 | 2 | PODXL, MAPT |
cytoskeleton organization (GO:0007010) | 3.22 | 2 | MAPT, ATXN3 |
positive regulation of purine nucleotide metabolic process (GO:1900544) | 4.85 | 2 | PARK7, PINK1 |
nervous system development (GO:0007399) | 3.53 | 2 | NR4A2, ATXN3 |
negative regulation of stress-activated MAPK cascade (GO:0032873) | 6.02 | 2 | PARK2, PINK1 |
carbohydrate metabolic process (GO:0005975) | 3.26 | 2 | GBA, SYNJ1 |
regulation of peptide secretion (GO:0002791) | 4.38 | 2 | PLA2G6, PARK2 |
regulation of calcium ion transport (GO:0051924) | 4.38 | 2 | PLA2G6, SNCA |
microtubule-based movement (GO:0007018) | 4.39 | 2 | UCHL1, MAPT |
regulation of peptide hormone secretion (GO:0090276) | 4.41 | 2 | PLA2G6, PARK2 |
positive regulation of neuron projection development (GO:0010976) | 4.26 | 2 | MAPT, PARK2 |
positive regulation of mitochondrial electron transport, NADH to ubiquinone (GO:1902958) | 9.04 | 2 | PARK7, PINK1 |
regulation of cell cycle G1/S phase transition (GO:1902806) | 4.74 | 2 | GIGYF2, FBXO7 |
negative regulation of cell cycle G1/S phase transition (GO:1902807) | 5.14 | 2 | GIGYF2, FBXO7 |
regulation of hormone secretion (GO:0046883) | 4.18 | 2 | PLA2G6, PARK2 |
regulation of microtubule polymerization or depolymerization (GO:0031110) | 5.74 | 2 | MAPT, SNCA |
single-organism intracellular transport (GO:1902582) | 3.59 | 2 | UCHL1, MAPT |
positive regulation of endocytosis (GO:0045807) | 4.98 | 2 | SYNJ1, SNCA |
positive regulation of cellular component biogenesis (GO:0044089) | 3.71 | 2 | MAPT, PINK1 |